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The National Center on Birth Defects and Developmental Disabilities at the Centers for Disease 
Control and Prevention, in collaboration with the National Task Force on Fetal Alcohol Syndrome 
and Fetal Alcohol Effect, is pleased to present Fetal Alcohol Syndrome: Guidelines for Referral and 
Diagnosis. This document represents the deliberations of clinicians, researchers, parents, and repre­
sentatives of governmental and non-governmental organizations, whose main goals were to increase 
the identification of individuals with fetal alcohol syndrome (FAS) using uniform criteria, and to 
improve the delivery of appropriate services to those individuals and their families. These new 
guidelines will help achieve those goals by educating medical and allied health professionals about 
FAS. 
In 2003, we, in the FAS research and practice communities, celebrated the 30th anniversary of the 
first reports describing fetal alcohol syndrome.  Since that time we have learned a great deal about 
this preventable condition.  We now recognize that FAS represents the tip of the iceberg and that 
there is a continuum of outcomes associated with prenatal exposure to alcohol.   These guidelines 
were undertaken, in part, as an effort to facilitate further identification, understanding, and study 
of all conditions resulting from prenatal exposure to alcohol.  They build on previous work and 
incorporate important scientific and clinical knowledge that has been obtained in recent years. 
CDC is pleased to provide continuing support for the expansion and refinement of scientific 
descriptions for FAS and other disorders related to prenatal exposure to alcohol through its ongoing 
work with the National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect and the 
federal Interagency Coordinating Committee on Fetal Alcohol Syndrome (ICCFAS).   
Preventing all adverse outcomes associated with prenatal alcohol exposure remains a primary goal of 
CDC, as well as the entire U.S. Department of Health and Human Services. CDC is committed to 
working with other federal agencies, organizations in the private sector, relevant partners, and the 
public to achieve this goal.  Similarly, CDC is committed to enhanced early identification of indi­
viduals with FAS and related disorders to ensure their access to appropriate services.  These latest 
guidelines for referral and diagnosis are an important step towards that goal.  Together we will 
ensure all persons with FAS and related disorders develop optimally and reach their full potential.  
José  F. Cordero, M.D., M.P.H. 
Assistant Surgeon General 
Director 
National Center on Birth Defects and Developmental Disabilities 
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As part of the fiscal year 2002 appropriations funding legislation, the U.S. Congress mandated that 
the Centers for Disease Control and Prevention (CDC), acting through the National Center on 
Birth Defects and Developmental Disabilities (NCBDDD) Fetal Alcohol Syndrome (FAS) 
Prevention Team and in coordination with the National Task Force on Fetal Alcohol Syndrome and 
Fetal Alcohol Effect (NTFFAS/FAE), other federally funded FAS programs, and appropriate non­
governmental organizations, would: 
• Develop guidelines for the diagnosis of FAS and other negative birth outcomes resulting from 
prenatal exposure to alcohol, 
• Incorporate these guidelines into curricula for medical and allied health students and practition­
ers, and seek to have them fully recognized by professional organizations and accrediting boards, 
and 
• Disseminate curricula to and provide training for medical and allied health students and practi­
tioners regarding these guidelines. 
Through the coordinated efforts of CDC, the NTFFAS/FAE, and a scientific working group 
(SWG) of experts in FAS research, diagnosis, and treatment, the following diagnostic criteria were 
developed over a 2-year period: 
Facial dysmorphia 
Based on racial norms, individual exhibits all three characteristic facial features: 
• Smooth philtrum (University of Washington Lip-Philtrum Guide rank 4 or 5) 
• Thin vermillion border (University of Washington Lip-Philtrum Guide rank 4 or 5) 
• Small palpebral fissures (at or below 10th percentile ) 
Growth problems 
Confirmed prenatal or postnatal height or weight, or both, at or below the 10th percentile, docu­
mented at any one point in time (adjusted for age, sex, gestational age, and race or ethnicity). 
Central Nervous System Abnormalities 
I. Structural 

1) Head circumference (OFC) at or below the 10th percentile adjusted for age and sex.

2) Clinically significant brain abnormalities observable through imaging.
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II. Neurological 
Neurological problems not due to a postnatal insult or fever, or other soft neurological signs 
outside normal limits. 
III. Functional 
Performance substantially below that expected for an individual’s age, schooling, or circum­
stances, as evidenced by: 
1. Global cognitive or intellectual deficits representing multiple domains of deficit (or significant 
developmental delay in younger children) with performance below the 3rd percentile (2 stan­
dard deviations below the mean for standardized testing) 
or 
2. Functional deficits below the 16th percentile (1 standard deviation below the mean for stan­
dardized testing) in at least three of the following domains: 
a) cognitive or developmental deficits or discrepancies 
b) executive functioning deficits 
c) motor functioning delays 
d) problems with attention or hyperactivity 
e) social skills 
f ) other, such as sensory problems, pragmatic language problems, memory deficits, etc. 
Maternal Alcohol Exposure 
I. Confirmed prenatal alcohol exposure 
II. Unknown prenatal alcohol exposure 
Criteria for FAS Diagnosis 
Requires all three of the following findings: 
1. Documentation of all three facial abnormalities (smooth philtrum, thin vermillion border, 
and small palpebral fissures); 
2. Documentation of growth deficits 
3. Documentation of CNS abnormality 
A primary goal of these guidelines is to provide standard diagnostic criteria for FAS so that consis­
tency in the diagnosis can be established for clinicians, scientists, and service providers. The guide­
lines are based on state-of-the-art scientific research, clinical expertise, and family input regarding 
the physical and neuropsychological features of FAS. The SWG sought to harmonize these guide­
lines with other diagnostic systems currently in use in this country and others (e.g., Canada). The 
SWG strove to provide a balance between conservative and overly inclusive diagnostic systems. 
Differential diagnosis from other genetic, teratological, and behavioral disorders was emphasized. 
In addition to diagnostic guidelines, guidance about medical, educational, social, and family servic­
es appropriate for individuals with FAS and their families are reviewed. Services that are applicable 
to all individuals with FAS and their families, as well as age-specific services, are included. Such 
services focus on increasing parent and professional knowledge of FAS, characteristics of the disor­
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der, differences between FAS and other disorders, and appropriate techniques for parenting or edu­
cating affected individuals. 
Prevention of FAS and related disorders is of tremendous public health importance. A large amount 
of research in recent years has enabled researchers and service providers to develop programs that 
are effective and targeted to specific populations for reducing the risk of an alcohol-exposed preg­
nancy, which prevents FAS. This research is reviewed herein and recommendations for identifying 
and intervening with women at risk for an alcohol-exposed pregnancy are provided. 
Finally, these guidelines are not intended to be an endpoint in the discussion of diagnosing FAS. 
There is a great need to acquire science-based information that will facilitate diagnostic criteria for 
additional related disorders, such as Alcohol Related Neurodevelopmental Disorder (ARND). These 
guidelines conclude with a call for further research and continuous refinement of the diagnostic cri­
teria for FAS and related conditions so that affected individuals and their families can receive 
important services that enable them to achieve healthy lives and reach their full potential. 
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Fetal Alcohol Syndrome: 

Guidelines for Referral and Diagnosis 

Substantial empirical and clinical scientific evidence has shown that prenatal exposure to alcohol 
causes damage to the developing fetus. Such exposure is commonly cited as the leading preventable 
cause of birth defects and developmental disabilities (1-3). Children* exposed to alcohol during 
fetal development can suffer multiple effects. While the number and severity of negative effects can 
range from subtle to serious, the negative consequences are lifelong. The effects of prenatal exposure 
to alcohol and basic diagnostic features of fetal alcohol syndrome (FAS) were first described in the 
United States (U.S.) medical literature 30 years ago (4-8). In 1981, the U.S. Surgeon General 
issued a public health advisory warning that alcohol use during pregnancy could cause birth defects 
(9). Further, mandated labeling of alcohol products was established in 1989 (10). Despite the 
known adverse effects of prenatal exposure to alcohol, many children who experience these adverse 
effects do not receive proper diagnosis due to the absence of current diagnostic guidelines. These 
current guidelines, which were federally mandated of the Centers for Disease Control and 
Prevention (CDC) in the U.S. Department of Health and Human Services (DHHS) 2002 
Appropriations Bill, seek to update and refine diagnostic and referral criteria in light of the scientif­
ic and clinical advances in the understanding of this disorder during the past 30 years. 
These guidelines are organized into several sections. Background information and a history of the 
development of these guidelines are presented. Next, revised and refined diagnostic and referral cri­
teria for FAS are described, including the empirical and clinical evidence that support each criteri­
on. Comparison of these guidelines with other diagnostic methods currently in use is provided. 
Because diagnosis is not the endpoint for most clinicians who see children with FAS, a discussion of 
the essential services for affected individuals is included. Likewise, prevention of FAS by reducing 
the number of alcohol-exposed pregnancies is inherent in dealing with the disorder. Therefore, a 
discussion focused on identifying and intervening with women at risk for an alcohol-exposed preg­
nancy is provided. Finally, a discussion of future needs and efforts related to FAS and other prenatal 
alcohol-related disorders conclude this report. 
BACKGROUND 
Prevalence. Studies by CDC have reported FAS prevalence rates from 0.2 to 1.5 cases per 1,000 
births across various populations (11-14). Other studies reflecting a variety of ascertainment 
methodologies have produced estimates ranging from 0.5 to 2.0 cases per 1,000 live births (15-16). 
Such rates are comparable with or above other common developmental disabilities such as Down 
syndrome or Spina Bifida (17). Using the CDC FAS estimates, among the approximately 4 million 
infants born each year, an estimated 1,000 to 6,000 will be born with FAS. Studies of particularly 
vulnerable populations yield prevalence estimates that far exceed those of other common disabili­
ties. Disadvantaged groups, Native Americans, and other minorities have been documented to have 
* Although referral and diagnosis for FAS can be made throughout the lifespan, the majority of individuals are referred 
and diagnosed in childhood. Thus, the terms “child” or “children” as used in these guidelines are not intended to pre­
clude referral, assessment, and diagnosis of older individuals. 
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rates as high as three to five FAS affected children per 1,000 children (18-20). Available data also 
suggest that poverty is strongly associated with women’s alcohol use before and during pregnancy, 
leading to an excess of children with FAS in impoverished groups (21-22). 
The magnitude of the problem is even greater when the risk of FAS is considered by looking at the 
rate of alcohol-exposed pregnancies. In 1999, over half of all U.S. women of childbearing age 
reported alcohol consumption in the past month (23). The large majority of these women drank 
only occasionally, but 15% could have been classified as moderate or heavy drinkers (24-25). 
During that same period, 13% of women reported consuming five or more drinks on one occasion 
(binge drinking) in the past month (26). Given that nearly half of all U.S. pregnancies are unin­
tended, and that millions of fertile women are sexually active while not using adequate contracep­
tion, an estimated 2% of women could be at risk for an alcohol-exposed pregnancy annually (27). 
More recently, higher rates have been found among subgroups of women, such as those treated for 
alcohol and drug problems, and women who have been incarcerated (28). Alcohol-related risk fac­
tors include drinking during pregnancy, pattern of alcohol use, alcohol dependence, use of multiple 
substances, having had a previous alcohol-exposed pregnancy, and having a partner or family mem­
ber who drinks heavily (29-31). Women who receive little or no prenatal care, are unemployed, are 
socially transient, have lost children to foster or adoptive care because of neglect, abuse, or aban­
donment are more likely to have high alcohol use patterns that could affect a pregnancy (22,32). 
National survey data indicate that, while the percentage of women who abstain from alcohol use 
during pregnancy has increased slightly in recent years, 13% of women continue to use alcohol 
during pregnancy (26). Among pregnant women, approximately three percent report binge drink­
ing (i.e., five or more drinks on any one occasion) or frequent drinking (i.e., seven or more drinks 
per week or five or more drinks on any one occasion) (1,33-34). Clearly, current prevalence rates of 
affected individuals and alcohol-exposed pregnancies indicate that the magnitude of the problem of 
FAS is a significant public health concern. However, because of the challenges of establishing accu­
rate and timely prevalence information, the magnitude could be even greater than current data 
indicate. 
Challenges in determining accurate prevalence. Despite the progress made over the past several 
decades to accurately establish and monitor the prevalence of FAS, the full magnitude of the prob­
lem is still not known. Primary care providers and others who care for children do not routinely or 
consistently identify individuals with FAS, which hinders efforts to account for these children in 
routine birth defects and developmental disabilities monitoring programs. Studies using multiple 
data sources (e.g., birth certificates, clinical charts, and medical records) show wide variations in 
identification of FAS cases depending on the population being surveyed (15,34). Four major factors 
lead to widespread failure to recognize FAS in primary pediatric care settings resulting in underesti­
mates of the prevalence and impact of FAS (36-38): 
• No specific and uniformly accepted diagnostic criteria have been available. The four broad areas 
of clinical features that constitute the diagnosis of FAS have remained essentially the same since 
first described in 1973: selected facial malformations, growth retardation, Central Nervous 
System (CNS) abnormalities, and maternal alcohol consumption during pregnancy. These four 
areas were reaffirmed in a 1996 report by the Institute of Medicine (IOM; 39-40). However, 
these broad areas of diagnostic criteria are not sufficiently specific to ensure diagnostic accuracy, 
consistency, and reliability . For example, clinicians do not have guidance about how many facial 
features must be present or the timing and severity of growth retardation needed to constitute 
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FAS diagnostic criteria. Thus, health providers are hampered in their efforts to screen and identify 
children with FAS. 
• FAS diagnosis is based on clinical examination of features, but not all children with FAS look 
or act the same. Because each of the symptoms has a broad range of differential diagnoses, it is 
easy for a clinician to miss or misdiagnose FAS. Previous guidelines, including those included in 
the 1996 IOM report, did not account for children of different racial and ethnic groups or indi­
viduals of different ages . In addition, symptoms such as growth impairment, cognitive impair­
ment, and learning disabilities can have a range of causes. Some of these causes or disorders have 
higher visibility and recognition than FAS, leading to misdiagnosis (or at least failure to include 
FAS in the total diagnosis). For instance, physicians are aware of the high prevalence of Attention 
Deficit, Hyperactivity Disorders (ADHD), but might not link attention problems to FAS. 
Without clear diagnostic criteria and instruction on their use, providers will continue to under-
identify and under-diagnose FAS. 
• Lack of knowledge and misconceptions among primary care providers. Many professionals 
believe that FAS can only occur if the mother is an alcoholic. Few know about the full range or 
progressive nature of the neurobehavioral symptoms that result from prenatal exposure to alcohol. 
Some incorrectly believe that FAS only occurs among low-income families or in Native American 
or other racial and ethnic minority groups (21). Better information on the impact of FAS among 
all populations and dissemination of race or ethnic variations in the diagnostic criteria can help 
clinicians understand the risk of prenatal alcohol exposure across populations. Knowledge about 
subpopulation variations in facial characteristics as well as growth curves for infants by gestational 
age also are important considerations (41). 
• Lack of diagnostic criteria to distinguish FAS from other alcohol-related conditions. Creating 
and using diagnostic guidelines for FAS is a starting point for better defining the continuum of 
conditions related to prenatal alcohol exposure (40). FAS is a severe outcome of prenatal alcohol 
exposure. Other outcomes also occur and can result in major deficits. Terms such as Fetal Alcohol 
Effect (FAE), Alcohol-related Birth Defect (ARBD), and Alcohol-Related Neurodevelopmental 
Disorder (ARND) have been used to describe a spectrum of conditions related to prenatal alcohol 
exposure. 
These four challenges indicate that what is urgently needed to advance the field of FAS diagnosis 
are current diagnostic guidelines based on empirical evidence as well as clinical experience. Such 
guidelines should be based on up-to-date scientific evidence and current clinical practices. Further, 
such guidelines would allow public health and service professionals to better determine the impact 
of FAS, and deliver needed services to affected children. 
Congressional mandate. As part of the fiscal year 2002 appropriations funding legislation, Congress 
mandated that CDC, acting through the National Center on Birth Defects and Developmental 
Disabilities (NCBDDD) and in coordination with the National Task Force on Fetal Alcohol 
Syndrome and Fetal Alcohol Effect (NTFFAS/FAE ), other federally funded FAS programs, and 
appropriate nongovernmental organizations, would: 
• Develop guidelines for the diagnosis of FAS and other negative birth outcomes resulting from 
prenatal exposure to alcohol; 
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• Incorporate these guidelines into curricula for medical and allied health students and practition­
ers, and seek to have them fully recognized by professional organizations and accrediting boards; 
and 
• Disseminate curricula to and provide training for medical and allied health students and practi­
tioners regarding these guidelines. 
Limit in scope. The mandate to CDC indicates that, in addition to guidelines for FAS, guidelines 
should be developed for other negative birth outcomes resulting from prenatal exposure to alcohol. 
However, it was subsequently determined through discussions with all interested stakeholders that 
the best course was to first develop guidelines for the full FAS diagnosis (see following). Then, in 
subsequent efforts, these guidelines could be expanded or refined to include other alcohol-related 
disorders. This approach was determined to provide the most timely and scientifically grounded 
guidelines at this time. However, this decision does not curtail ongoing efforts to define conditions 
beyond FAS or develop diagnostic guidelines for those conditions. 
Note on terminology. Many terms are used to describe the continuum of effects that result from pre­
natal exposure to alcohol, including: Fetal Alcohol Effect, Alcohol-related Birth Defects, and 
Alcohol-Related Neurodevelopmental Disorder. A more recent term that has been introduced is 
Fetal Alcohol Spectrum Disorders (FASD). In April 2004, several federal agencies [(National 
Institutes of Health (NIH), CDC, & Substance Abuse and Mental Health Services Administration 
(SAMHSA)] along with experts in the field were convened at a summit sponsored by the National 
Organization on FAS (NOFAS) to develop a consensus definition of FASD. The resulting defini­
tion, adopted in these guidelines, is: 
Fetal Alcohol Spectrum Disorders (FASD) is an umbrella term describing the range of effects that can 
occur in an individual whose mother drank alcohol during pregnancy. These effects may include 
physical, mental, behavioral, and/or learning disabilities with possible lifelong implications. The term 
FASD is not intended for use as a clinical diagnosis. 
APPROACH AND METHODS FOR DEVELOPMENT OF GUIDELINES 
To meet its Congressional mandate, CDC convened an internal working group, led by staff from 
the FAS Prevention Team of NCBDDD, to conduct preplanning meetings to determine the best 
methods for development of all aspects of the guidelines: (a) general framework for referral and 
diagnosis, (b) development of guidelines for physical features (dysmorphia and growth) as well as 
exposure, and (c) development of guidance to clinicians concerning potential CNS abnormalities. 
Each of these aspects involved review of the literature, as well as discussions with consultants, clini­
cians, researchers, and parents of affected children. A description of general and specific methods of 
development of each aspect follows. 
General review of literature. CDC staff identified various reports and documents to be used as the 
scientific basis for diagnostic guidelines. The science base for this work included, but was not limit­
ed to: 
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• Published scientific, peer-reviewed, literature on physical and neurodevelopmental effects of pre­
natal exposure to alcohol; 
• The report of the IOM Committee to study FAS (40); 
• Results from the work of the NTFFAS/FAE (42) ; 
• Criteria from standard, widely used dysmorphology and neurodevelopmental textbooks or guides 
(40,43-44); 
• Research on measuring the FAS facial phenotype (45-47); 
• Reports on systems that operationally interpret the 1996 IOM criteria(48-50); 
• Experience in developing a surveillance case definition for the Fetal Alcohol Syndrome 
Surveillance Network (FASSNET) (51); 
• Ongoing state surveillance and research data, particularly work of Alaska (19,35,52), Colorado 
(53), New Jersey, Nevada, Washington, and the Four State FAS Consortium (consisting of North 
Dakota, Montana, Minnesota, and South Dakota); 
• The American Academy of Pediatrics (AAP) August 2000 statements and recommendations on 
FAS and other effects related to maternal alcohol use (54); Position of the American Academy of 
Family Physicians, which refers to the AAP statement; and 
• Canadian National Committee’s efforts concerning standardization of guidelines for screening, 
diagnosis, and surveillance of FAS. 
Framework. Before developing the specifics of the diagnostic and referral guidelines, CDC staff 
determined that it would be helpful to conceptualize the entire diagnostic and referral process 
encountered by affected individuals and their families. Such a framework also would assist profes­
sionals in understanding their specific role in the referral and diagnostic process, as well as guide 
them with next steps for each case. The framework was reviewed by health care policy consultants 
as well as members of the NTFFAS/FAE. Revisions were made based on their suggestions. This 
framework is presented in detail later in these guidelines. 
Creation of the Scientific Working Group. The first step in development of the guidelines was to con­
vene an internal CDC working group. The group consisted of members of the NCBDDD FAS 
prevention team, geneticists, developmental pediatricians, epidemiologists, and psychologists, as 
well as other allied health professionals. This internal working group developed a list of potential 
external experts who could be convened to develop the actual guidelines. The large external panel 
of experts was designated as a scientific advisory panel. From this panel, a subset of experts formed 
a Scientific Working Group (SWG) that delineated the specifics of the diagnostic criteria. 
The external SWG convened by CDC included researchers, clinicians in general and specialty med­
icine, representatives from academic centers and state health agencies, as well as consumer represen­
tatives from the National Organization on FAS (NOFAS) and The Arc of the United States. The 
scientific advisory panel met in Atlanta, Georgia, on July 12, 2002, to begin deliberations on the 
proposed guidelines. At that meeting, four subgroups were created: FAS Referral and Diagnosis; 
ARND issues; Essential Services for Children with FAS/ARND; and Identifying and Intervening 
with Women at Risk for an Alcohol-Exposed Pregnancy. The subgroups met and began delibera­
tions related to the guidelines in their respective topic areas. 
A subsequent meeting of the SWG occurred on September 20, 2002, in conjunction with an NTF-
FAS/FAE meeting, also in Atlanta. This offered the opportunity for information sharing and feed­
back on progress made thus far from a range of stakeholders represented on the NTFFAS/FAE 
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(e.g., parents, providers, and researchers). The FAS Referral and Diagnostic subgroup and the 
Essential Services subgroup met to further deliberate on their recommendations. The recommenda­
tions from these two subgroups were then presented to the NTFFAS/FAE for review and input. 
The component of the criteria for FAS screening and diagnosis that presented the most difficulty to 
the FAS Referral and Diagnosis subgroup was the central nervous system (CNS)/neurobehavioral 
component. This group felt that members of the ARND subgroup were most qualified to develop 
that particular component of the criteria. 
The ARND subgroup drew important information from a poll of the experts that was conducted to 
identify the CNS/neurobehavioral domains most affected by prenatal alcohol exposure (further 
description follows). Results of this poll were incorporated into the FAS Referral and Diagnosis 
Guidelines within the CNS/neurobehavioral component. The third meeting of the FAS Referral 
and Diagnosis subgroup was teleconferenced on March 11, 2003, and draft guidelines were 
reviewed and revised. At that time and based on review of the available scientific evidence concern­
ing diagnosis of ARND, the scope of the guidelines was limited to FAS, with future efforts to be 
devoted to other prenatal alcohol-related disorders. This revised version of the diagnostic criteria 
was presented to and approved by the NTFFAS/FAE on March 13, 2003 with recommendations. 
Consensus among members of the external SWG and the NTFFAS/FAE was used to finalize each 
criterion of the guidelines for dysmorphology, growth, and prenatal exposure to alcohol. At the 
December 8 and 9, 2003, meeting of the NTFFAS/FAE, further discussions were held regarding 
the CNS/neurobehavioral criteria and subsequent revisions were made. Finalization of the FAS cri­
teria was reached during a teleconference of the NTFFAS/FAE on May 13, 2004. 
Highlights of deliberations of SWG: Physical criteria. The SWG concluded that a strict definition of 
FAS should be established first, not including diagnostic terms such as fetal alcohol effect (FAE), 
alcohol-related neurodevelopment disorder (ARND), and alcohol-related birth defect (ARBD) at 
this time because of insufficient scientific evidence on which to base diagnostic criteria for these 
related conditions. The SWG urged that CDC diagnostic guidelines for FAS use objective, quanti­
tative measures to improve accuracy and reproducibility and apply specific case definitions guided 
by evidence-based knowledge and new technologies. The SWG also recommended use of racial and 
ethnic norms for facial features, head circumference (occipitofrontal circumference, OFC), and 
other key features when available. 
During its deliberations, the SWG acknowledged the need to keep recommendations for the diag­
nosis of FAS relevant to practitioners working in clinical settings. Also, the SWG acknowledged dif­
ferences between screening, diagnosis, surveillance, and research activities and the separate defini­
tional needs of each of these activities. Effective tools and practical strategies for primary care set­
tings were considered. The SWG encouraged CDC to call for action and collaboration among 
obstetricians, pediatricians, family practice physicians, and others providing primary care and 
screening services to children. The SWG also discussed the need for more data regarding the range 
of essential services for children who are diagnosed positive for FAS and stressed the importance of 
a multidisciplinary plan for care that links to the child’s community healthcare provider or medical 
home. 
Central nervous system abnormality criteria. Because the scientific evidence and professional consen­
sus on CNS criteria are not yet at the level of specificity equal to that available for physical features, 
a different approach was used in developing CNS criteria. Further, it was decided that rather than 
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creating strict criteria for specific CNS domains and level of severity needed, more general guide­
lines should be described. Such general guidelines should assist the clinician in identifying areas of 
deficit most likely to be found with individuals who have FAS, as well as individuals with FAS who 
have less common types of deficits. This approach was considered optimal because a number of 
structures of the brain are affected versus a single, isolated structure. This generalized nature of 
damage from prenatal alcohol exposure can result in a wide array of neurodevelopmental outcomes. 
To develop such neurodevelopmental guidelines for referral and diagnosis for FAS, the 
ARND/CNS subgroup polled clinicians and researchers who have extensive knowledge and experi­
ence with individuals who have FAS or other related diagnoses. These experts were individuals who 
specialize in neurobehavioral issues, have extensive research and clinical experience making the 
FAS/ARND diagnosis, and have contact with families and children with FAS. They were queried to 
find out what behavioral domains they encountered most frequently or were most essential for 
making an FAS/ARND diagnosis. Twenty-two clinicians were contacted and their responses were 
synthesized. The clinicians were asked to identify five areas of deficit they considered most impor­
tant for diagnosis of FAS or related disorders. In addition, the clinicians were also asked to identify 
three to five specific behaviors that could be used as examples of each of the five areas of deficit. 
The resulting guideline of neurodevelopmental features associated with FAS are presented as being 
as inclusive as possible, while understanding that certain areas of neurodevelopmental functions are 
more vulnerable to prenatal exposure to alcohol. Each domain is presented so as to include exem­
plars from direct observation or parent report that can be documented through standardized test­
ing. 
Medical diagnostic criteria are generally evaluated in two ways: (1) the criteria must be reliable and; 
(2) the criteria must be as valid as possible. The criteria that appear in these diagnostic guidelines 
meet both of these requirements. In developing these diagnostic guidelines, the SWG also consid­
ered the feasibility of applying the criteria in primary care practice and related settings where chil­
dren are seen. 
DIAGNOSTIC AND REFERRAL FRAMEWORK 
The framework in Figure I was developed to help guide the discussions of the SWG as they deliber­
ated on the guidelines for referral and diagnosis of FAS. The framework was developed to provide 
an overview of the entire identification, referral, diagnosis, and treatment process. This overview 
guided the SWG in identifying key points that needed to be addressed to develop specific guide­
lines. The framework reflects CDC’s recommendation that developmental screening be implement­
ed to improve children’s health and help them reach their full potential. A discussion of the major 
points of the framework follows. 
Initial identification. Initial recognition that a child or older individual has a potential problem can 
come from many sources. Often, parents notice differences between a child and his or her siblings. 
School systems, including Head Start and daycare staff, interact with a large number of children 
and often recognize when someone is having difficulty. Social service professionals, such as WIC 
clinic staff, social workers, and foster care agencies frequently recognize children and individuals 
having difficulty and needing evaluation. And finally, healthcare providers (particularly pediatri­
cians) often are the first to screen for and detect problems; or obstetricians, who might be aware of 
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FIGURE 1. Framework for FAS Diagnosis and Services 
a maternal substance abuse problem, might refer a newborn. Recognition of many of the problems 
associated with FAS is exactly the type of condition the “well child” visits to the doctor’s office are 
meant to identify. It is assumed that triggers, such as facial abnormalities, growth delay, develop­
mental problems, or maternal alcohol use, will emerge from the contact. Recognition of a potential 
problem should lead the provider, regardless of specific profession, to facilitate getting the person 
and his or her family to the appropriate next step. 
Referral. The referral process is initiated at the point a clinician starts to have suspicions of an alco-
hol-related disorder for a child. This process is facilitated by thorough knowledge of the physical 
and neurodevelopmental domains affected in individuals with FAS, as well as characteristics that 
could trigger a referral. Examples of triggers are presented later, in the Referral section of these 
guidelines. In making a referral for a complete diagnostic evaluation for FAS, it is helpful for the 
referring provider to gather and document specific data related to the FAS criteria. These data will 
assist the provider in making the decision to diagnose the child or to refer the child to a multidisci­
plinary evaluation team for a confirmed diagnosis. In addition, these data could be forwarded to 
the multidisciplinary evaluation team to guide the diagnostic process. A complete review of systems, 
noting features consistent with FAS, would be most productive. 
Diagnosis. At this stage, the child would be presented to a multidisciplinary team who would 
engage in a more thorough assessment of the child using FAS diagnostic procedures to evaluate dys­
morphia and growth parameters, as well as obtain appropriate neurodevelopmental evaluation data. 
Once a diagnosis is made, an intervention plan would be developed using a multidisciplinary team 
approach. A variety of specialists could contribute to the multidisciplinary team, including dysmor­
phologists, developmental pediatricians, psychiatrists, psychologists, social workers, and educational 
specialists. Other clinicians, such as pediatricians and family practitioners, also might make the FAS 
diagnosis, with appropriate training in use of these guidelines. In many rural and less populated 
regions, these clinicians must make the diagnosis for many types of birth defects and developmental 
8 
Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis 
disabilities. Many of these evaluation services are available within the community setting, for exam­
ple school systems could provide neurocognitive assessments. 
DIAGNOSTIC CRITERIA 
Dysmorphia. Human congenital malformations are referred to as dysmorphic features or dysmor­
phia (55). Dysmorphia occurs when normal morphogenesis is interrupted, creating a particular fea­
ture which is shaped, sized, or positioned outside the normal range of development. Alcohol is a 
teratogen that results in dysmorphia through interference with nerve cell development and func­
tioning, alterations in the ability of cells to grow and survive, increased formation of cell-damaging 
free radicals, altered pathways of biochemical signals within cells, and altered expression of certain 
genes and genetic information. In short, alcohol has been shown to interfere with fetal nerve cell 
development and function in a variety of ways (56-57). 
In first describing the dysmorphic features of FAS, Jones and colleagues focused on short palpebral 
fissure, maxillary hypoplasia (with prognathism), and the presence of epicanthal folds that were 
observed for a majority of the children described. However, other features also were noted for some 
patients, including altered palmar fexional crease patterns (i.e., hockeystick crease), cardiac anom­
alies, joint disability, overlapping fingers, ear anomalies, hemangiomas, ptosis, hypoplastic nails, and 
pectus deformities (4,5). Over the next 30 years, additional features described included: micro­
cephaly, short nose, smooth philtrum with thin vermillion border, cleft lip, micrognathia, protrud­
ing auricles, short or webbed neck, vertebra and rib anomalies, short metacarpal bones, 
menigomyelocele, hydrocephalus, and hypoplastic labia majora (43). 
Despite the heterogeneity of expression for dysmorphic features related to prenatal exposure to alco­
hol, core facial dysmorphia have emerged through human and animal studies. Experimental studies 
with a mouse model and primates indicate that the facial dysmorphia observed for individuals with 
FAS are the result of disturbances of cellular migration during organogenesis along the midline of 
the face (58). Using anthropomorphic measurements of all facial features, clinical researchers have 
confirmed the midline feature abnormalities (59). Studies of clinic-referred samples also support 
these features as discriminant for FAS (60-61). Based on these scientific findings and the extensive 
clinical experience of the SWG, the following facial dysmorphic features were determined to meet 
the dysmorphia criteria essential for FAS (based on racial norms): 
• Smooth philtrum (measured as 4 or 5 on Lip-Philtrum Guide*) 
• Thin vermillion border (measured as 4 or 5 on Lip-Philtrum Guide) (i.e., upper lip) 
• Small palpebral fissures (measured as ≤10th percentile according to age and racial norms) 
The individual must exhibit all three characteristic facial features; however, additional features also 
can be present. For example, maxillary hypoplasia is often noted for individuals with FAS as well as 
those associated features described previously. Cross-sectional and longitudinal studies indicate that 
many features can change with age or development. After puberty, the characteristic facial features 
associated with FAS can become more difficult to detect (62). However, recent findings indicate 
that these three key features remain for the majority of individuals with FAS (47,50). 
* University of Washington Lip-Philtrum Guide (49-50). 
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Use of these three cardinal features (smooth philtrum, thin vermillion border, and small palpebral 
fissures) to assess whether an individual’s dysmorphia is consistent with FAS, is compatible with the 
IOM report and other diagnostic systems currently in use. Specific criteria were chosen by the 
SWG to maximize inclusiveness of potential cases on this diagnostic parameter and, therefore, 
might differ somewhat from other systems currently in use. For example, the 1999 version of 
University of Washington 4-digit code system uses the same philtrum and vermillion border criteria 
(as noted by reference to its Lip-Philtrum Guide), but uses a cutoff of the 3rd percentile (2 or more 
standard deviations below the norm) for palpebral fissures , which is a more conservative cutoff 
(50). This more conservative approach results in fewer individuals meeting the dysmorphia criteria 
for an FAS diagnosis but also reduces potential false positives for the diagnosis. Other ways to assess 
dysmorphia for the FAS diagnosis include checklists or weighted checklists (63-65). Of those 
checklists reviewed by the SWG, all designated the philtrum, vermillion border, and palpebral fis­
sures as the cardinal facial features of FAS (either by higher weighting or explicit notation). 
However, because of the cumulative nature of some such lists, an individual who has several of the 
associated features but not the cardinal features could still be given the FAS diagnosis. Thus, the 
checklists tend to be more inclusive than the current guidelines, with greater potential for false-pos-
itive diagnoses. Review of available diagnostic systems seems to indicate that the dysmorphic crite­
ria agreed upon by the SWG provide a balance between conservative and overly inclusive diagnostic 
systems. 
Differential diagnosis of dysmorphia. Individual dysmorphic features are not unique to any particular 
syndrome. Even rare defects or certain clusters of dysmorphic features can appear in a variety of 
syndromes. Therefore, a process of differential diagnosis is essential in making an accurate FAS 
diagnosis. Following, in Table 1 is a list of syndromes with dysmorphic features that overlap with 
the primary features of the FAS diagnosis (43). As can be seen from Table 1, none of the syndromes 
with single overlapping features (except for Toluene embryopathy) have the full constellation of 
small palpebral fissures, thin vermillion border, and smooth philtrum. However, there are some syn­
dromes in which the constellation of features (primary, occasional features, or both) give a “gestalt” 
that is similar to the “gestalt” of FAS. These syndromes should be considered in particular when 
completing the differential diagnosis. Table 2 lists these syndromes, along with the overlapping and 
differentiating features. 
Growth problems. Growth retardation, variably defined, has been documented consistently in indi­
viduals with FAS. However, these observations used a variety of parameters (e.g., height, weight, 
and head circumference), severity levels (below 25th percentile, below 10th percentile, or below 3rd 
or 2nd percentile), and timing of growth problems (current, birth or present at any point during 
life). The SWG reviewed available literature, clinical expertise, and practical issues to arrive at 
benchmarks for each of these three aspects of growth abnormalities. 
The primary parameters of growth that need to be impaired to meet the growth retardation criteria 
of FAS are height, weight, head circumference, or a combination thereof. Anecdotally, a small num­
ber of children with FAS have been found to have disproportionate height in relation to weight. 
However, because multiple organic factors can lead to growth deficiencies (e.g.,. brain structure 
abnormalities leading to poor skeletal growth or disruption of endocrine function leading to poor 
weight gain), and because most children with FAS are symmetrical for height and weight (66), it 
was determined that deficiencies in either height or weight, but not height for weight, should be 
included as growth parameters that might be affected by FAS. Thus, children with growth retarda­
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Table 1. Differential diagnosis of individual features associated with FAS 
Feature	 Syndromes 














































Note: Features that discriminate these disorders from FAS can be found in Jones, 1997. 
tion in height or weight would meet the growth retardation criteria for the FAS diagnosis. 
Consistent with poor brain development, it was determined that head circumference should be 
included as a CNS parameter rather than a growth parameter (67-68). 
Severity of growth retardation has been defined for each parameter as at or below the 10th per­
centile or at or below the 3rd percentile by a majority of FAS studies. The primary issue for severity 
is inclusion or exclusion of children for the FAS diagnosis. Use of the 10th percentile would result 
in more false-positive FAS diagnoses; while use of the 3rd percentile would result in a greater num­
ber of false-negatives. For public health reasons of capturing the largest number of children who 
might need services, the 10th percentile was chosen by the SWG. As noted previously in the dys­
morphia section, use of the 10th percentile strikes a balance among criteria used in other diagnostic 
systems. Again, the 1999 edition of the University of Washington 4-digit code takes a conservative 
approach, using the 3rd percentile as the cutoff. Checklist systems often do not specify a particular 
level of growth retardation and some do not specify which growth parameters should be considered 
(i.e., height, weight, or height relative to weight). This lack of specificity could lead to inconsistency 
in diagnostic method, which in turn, could lead to inconsistent application of the FAS diagnosis. 
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Table 2. Differential diagnosis of syndromes similar to FAS 










(Fetal dilantin syndrome) 
Fetal valproate syndrome 
Maternal PKU fetal 
effects 
Small nose with anteverted Rounded face, down-slant to palpe­
nares, broad philtrum, maxil­ bral fissures, widow's peak, crease 
lary hypoplasia, and wide- below lower lip, incomplete out 
spaced eyes  folding of upper helices, and dental 
eruption problems.  
Short palpebral fissures, antev- Wide mouth with full lips, stellate 
erted nares, long philtrum, pattern of the iris, periorbital full-
depressed nasal bridge, and ness, and connective tissue disor­
epicanthal folds ders. 
Low nasal bridge, wide-spaced Down-slant to palpebral fissures, 
eyes, and epicanthal folds  keratoconus, wide mouth, and pro­
truding upper lip 
Short palpebral fissures, wide Shallow supraorbital ridge with 
spaced eyes, and epicanthal nasal bridge near the level of the 
folds forehead, and broad nasal tip  
Long philtrum, thin vermil- Single, bushy eyebrow extending 
lion border, anteverted nares, across forehead, long eyelashes, 
and depressed nasal bridge downturned mouth, high arched 
palate, and short limbs (yielding 
short stature) 
Short palpebral fissures, mid- Micrognathia, large anterior 
face hypoplasia, smooth fontanel, down-turned mouth cor-
philtrum, and thin vermillion ners, hair patterning abnormalities, 
border bifrontal narrowing, and ear abnor­
malities 
Wide-spaced eyes and Short nose with bowed upper lip  
depressed nasal bridge 
Epicanthal folds, anteverted High forehead, infraorbital crease 
nares, long philtrum with thin or groove, and small mouth 
vermilion border, and wide-
spaced eyes 
Epicanthal folds, short palpe- Small upturned nose, round facies, 
bral fissures, long underdevel­ and prominent glabella 
oped philtrum, and thin ver­
million border 
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The current guidelines provide consistent growth parameters that should be assessed, as well as a 
more inclusive level of the 10th percentile. 
The primary issue that emerged in the discussion of timing of growth retardation was whether 
growth retardation needs to be present at the time of the diagnosis, or whether it could have 
occurred previously and been resolved. This is particularly important when including prenatal 
growth retardation or early growth problems due to failure to thrive. Because a great number of 
treatments exist for growth problems (e.g. feeding tubes or hormone therapy), the SWG adopted 
the criteria that any history of growth retardation, including prenatal growth deficiencies, should be 
allowed within the diagnostic criteria (61). 
Thus, the growth retardation criteria adopted by the SWG are: confirmed prenatal or postnatal 
height, weight, or both at or below the 10th percentile documented at any one point in time 
(adjusted for age, sex, gestational age, and race or ethnicity). The committee noted that the examin­
er should make sure that the single point in time when the growth deficit was present does not cor­
relate with a point in time when the child was nutritionally deprived. 
Differential diagnosis of growth problems. Growth retardation and growth deficiencies occur in chil­
dren, adolescents, and adults for a great many reasons. Some of the most obvious reasons have to 
do with insufficient nutrition. This could be a particular problem for infants with poor sucking 
responses who experience failure to thrive. In addition, several genetic disorders result in specific 
growth deficiencies (e.g., dwarfism). Prenatal growth retardation can be due to a variety of factors, 
including maternal smoking or other behaviors leading to hypoxia, poor maternal nutrition, or 
genetic disorders. Both environmental and genetic bases for growth retardation should be consid­
ered for differential diagnosis when considering the FAS diagnosis. 
Central nervous system abnormalities (CNS). More than 2,000 scientific papers regarding the terato­
genic effects of alcohol exposure for CNS have been published over the past 30 years (69-71). 
Studies of the impact of fetal exposure to alcohol show a range of short- and long-term cognitive 
and behavioral outcomes resulting from these CNS abnormalities. Complicating detection of these 
abnormalities is that FAS neurobehavioral presentation changes across the lifespan (4,61,72-79). 
Despite this developmental process, CNS deficits generally persist throughout the lifespan (80). 
Longitudinal studies have found that many adults affected by FAS have complex mental health dis­
orders, are affected by the consequences of neurobehavioral deficits, and are unable to sustain inde­
pendent living (81).Prenatal exposure to alcohol can result in an array of structural, functional, 
neurological problems, or a combination of these, as well as abnormalities of the CNS (40). To 
meet the FAS diagnostic criteria for CNS abnormality, structural, neurological, or functional 
deficits, or a combination thereof, must be documented. Note that it is also possible for an individ­
ual to present with more than one CNS structural, neurological, functional deficit or abnormality. 
Guidelines for each type of CNS abnormality follow. 
I. Structural 
1. Documented small or diminished overall head circumference (OFC at or below the10th per­
centile) adjusted for age and gender (including head circumference at birth; 4,68). For chil­
dren who have overall growth deficiency (i.e., height and weight below the 10th percentile) 
to meet this criteria for CNS abnormality, the child’s head circumference should be dispro­
portionately small to his or her overall size (i.e., OFC at or below the 3rd percentile). 
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2. Clinically significant brain abnormalities observable through imaging techniques (e.g. reduc­
tion in size, or change in shape of the corpus callosum, cerebellum, or basal ganglia) as 
assessed by an appropriately trained professional (4,58,82-88). 
Note: An individual could meet the CNS abnormality criteria for the FAS diagnosis through 
a structural abnormality, yet not demonstrate detectable functional deficits. 
II. Neurological 
Documented evidence of neurological damage to the CNS. Neurological problems of CNS can 
include seizures not due to a postnatal insult or fever or other soft neurological signs outside 
normal limits (e.g., in coordination, visual motor difficulties, nystagmus, or difficulty with 
motor control; 89-92). As with head circumference, abnormal neurological findings can be 
most predictive of underlying CNS abnormality due to prenatal alcohol exposure, rather than 
later environmental factors, in younger children. The use of norm-referenced measures of neu­
rological functioning is recommended. 
III. Functional 
Assessment findings that indicate deficits, problems, or abnormalities in functional skills of the 
CNS. Early brain damage is usually generalized rather than specific, with increased specificity of 
abnormalities revealed as development progresses. The functional abilities affected by prenatal 
exposure to alcohol vary greatly from person to person, depending on the amount of alcohol 
exposure, timing of exposure, and pattern of exposure (e.g., chronic exposure versus binge 
episodes). Despite this inherent variation in effects, several areas of significant functional vul­
nerability have been observed consistently by clinicians and clinical researchers with particular 
damage to corresponding structures reported (e.g., corpus callosum, cerebellum, or basal gan­
glia). Variability in exposure impact results in variability of structural, neurological, or function­
al deficits, or a combination thereof in affected individuals. 
For functional deficits, it is generally accepted that multiple locations in the brain (and correspon­
ding functional capability) are affected by prenatal exposure to alcohol. To address this issue, func­
tional deficits that fulfill the CNS abnormality criteria can be met in two ways: 
(1) Global cognitive deficit (e.g., decreased IQ) 

or significant developmental delay in children too young for an IQ assessment;

OR 
(2) Deficits in THREE or more specific functional domains 
These two ways of meeting the criteria for a functional CNS abnormality were adopted because of 
the composite nature of cognitive/intellectual and developmental measures (93-94). Decreased per­
formance on a standardized measure of cognition/intelligence or development assumes deficits in 
multiple domains. In the absence of such a measure, several specific domains need to be assessed 
individually to determine that multiple functional domains have been affected. The specific 
domains most often cited as areas of deficit or concern for individuals with FAS are described 
below, although other domains and abilities can be affected and this list is not exhaustive. It should 
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be noted that for each of the following specific domains described, other agents and environmental 
factors can produce deficits or outcomes similar to prenatal alcohol exposure, making care differen­
tial diagnosis essential. Finally, these descriptions are intended to be suggestive and examples of 
likely and possible problems a clinician might encounter then need to assess using psychometric 
instruments. The exemplars are not intended to be exhaustive, or to present a necessary list of 
behaviors to be used as a checklist without reliable and valid assessment. 
a) Cognitive deficits or significant developmental discrepancies. It is important to note that global 
deficits or delays can leave the child scoring in the normal range of development, but below what 
would be expected for his or her environment and background (61,95-99). In addition to formal 
testing (either through records or current testing), behaviors that may be observed (or reported) 
in the clinical setting that suggest cognitive deficits or developmental delays that should be 
assessed by standardized testing include but are not limited to specific learning disabilities (espe­
cially math and/or visual-spatial deficits); uneven profile of cognitive skills; poor academic 
achievement; discrepancy between verbal and nonverbal skills; and slowed movements or reac­
tion to people and stimuli (e.g., poor information processing). (75,100-103) 
b) Executive functioning deficits. Executive functioning (EF) is defined as the ability to maintain 
an appropriate problem solving set for attainment of a future goal and that this ability includes 
the more specific skills of inhibition, planning, and mental representation (104). Behaviors that 
can be observed (or reported) in the clinical setting that might indicate an EF deficit that should 
be assessed by standardized testing include, but are not limited to poor organization, planning, 
or strategy use; concrete thinking; lack of inhibition; difficulty grasping cause and effect; 
inability to delay gratification; difficulty following multistep directions; difficulty changing 
strategies or thinking of things in a different way (i.e., perseveration); poor judgment; and 
inability to apply knowledge to new situations. (105-108) 
c) Motor functioning delays or deficits. Both gross motor and fine motor skills can be impaired for 
individuals with FAS (109-111). Visual-motor/visual-spatial coordination is a particularly vulner­
able area of functioning (99,112-113). Behaviors that can be seen (or reported) in the clinical set­
ting that indicate motor problems that should be assessed by standardized testing include, but are 
not limited to delayed motor milestones; difficulty with writing or drawing; clumsiness; bal­
ance problems; tremors; and poor dexterity. For infants, a poor suck is often observed. 
(61,114-116) 
d) Attention and hyperactivity problems. Attention problems are often noted for children with 
FAS, with many children receiving a diagnosis of attention-deficit hyperactivity disorder (AD 
HD; 117). Although such a diagnosis can be applied, some research has shown that the attention 
problems for children with FAS do not seem to fit the classic pattern of ADHD. Individuals with 
FAS tend to have difficulty with the encoding of information and flexibility (shifting) aspects of 
attention; whereas children with ADHD typically display problems with focus and sustaining 
attention (118-119). Individuals with FAS also can appear to display hyperactivity because their 
impulsivity may lead to increased activity levels. Behaviors that may be observed (or reported) in 
the clinical setting that suggest attention problems related to FAS that should be assessed by stan­
dardized testing include, but are not limited to described by adult as “busy”; inattentive; easily 
distracted; difficulty calming down; overly active; difficulty completing tasks; and/or trouble 
with transitions. Parents might report inconsistency in attention from day to day (e.g., “on” 
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days and “off ” days). (79,120-125) 
e) Social skills problems. The executive, attention, and developmental problems described previous­
ly often lead to clinically significant difficulty for people with FAS when interacting with peers 
and others. Because of the mental representation problems, individuals with FAS often have 
social perception or social communication problems that make it difficult for them to grasp the 
subtler aspects of human interactions (107,126-127). Consistent difficulty understanding the 
consequence of behavior or inappropriate behavior is frequently described for individuals with 
FAS (62,80). Behaviors that can be observed (or reported) in the clinical setting that indicate 
these types of social difficulties that should be assessed by standardized testing include, but are 
not limited to lack of stranger fear; often scape-goated; naiveté and gullibility; easily taken 
advantage of; inappropriate choice of friends; preferring younger friends; immaturity; superfi­
cial interactions; adaptive skills significantly below cognitive potential; inappropriate sexual 
behaviors; difficulty understanding the perspective of others; poor social cognition; and clini­
cally significant inappropriate initiations or interactions. (128-130) It should be noted that 
standardized assessment of social problems can be quite difficult. Social functioning is a multifac­
eted domain that can require several areas of assessment. 
f )  Other potential domains that can be affected. In addition to these five most often cited prob­
lem areas, deficits and problems to be assessed by standardized testing can present in several other 
areas, including sensory problems (e.g., tactile defensiveness and oral sensitivity); pragmatic 
language problems (e.g., difficulty reading facial expression; poor ability to understand the per­
spectives of others); memory deficits (e.g., forgetting well-learned material, and needing many 
trials to remember); and difficulty responding appropriately to common parenting practices 
(e.g., not understanding cause-and-effect discipline). While abnormalities in these “other” areas 
have been reported for some individuals with FAS, expert consensus suggests deficits in these 
areas present at a lower frequency than do those in the other five specific domains (62). 
THESE GUIDELINES STRONGLY RECOMMEND THAT FUNCTIONAL DOMAINS BE ASSESSED USING 
NORM-REFERENCED STANDARDIZED MEASURES. DOMAINS SHOULD BE ASSESSED BY APPROPRIATE 
PROFESSIONALS USING RELIABLE AND VALIDATED INSTRUMENTS. 
Level of functional deficit. In these guidelines, global cognitive deficits and developmental delay, or 
deficits in three or more specific domains, are defined as performance substantially below that 
expected for an individual’s age, schooling, or circumstances. Several statistical thresholds have been 
suggested to operationally define performance substantially below expected levels. Previous research 
indicates that approximately only one-quarter of individuals diagnosed with FAS perform at the 
most conservative level of below the 3rd percentile (2 standard deviations below the mean) on stan­
dardized measures (95). In keeping with this finding, and to adequately capture the full spectrum 
of effects, the SWG adopted two levels of functional deficits that would meet the criteria for a CNS 
abnormality: (1) for significant global cognitive deficit performance below the 3rd percentile (i.e., 2 
standard deviations below the mean); and (2) for three or more specific domains performance 
below the 16th percentile (i.e., 1 standard deviation below the mean) on standardized measu res of 
individual domains. Thus, individuals scoring below the normal range on a global measure of IQ or 
development and individuals scoring in the below average range on standardized measures of three 
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specific functional domains would meet the criteria for functional CNS abnormality for diagnostic 
purposes. 
Ideally, functional deficits should be established through appropriate standardized neuropsychologi­
cal testing by a trained professional. The SWG recognized that such standardized testing might not 
be readily available in all diagnostic settings. Clinicians are strongly encouraged to supplement their 
observations by obtaining standardized testing through early intervention programs, public schools, 
and psychologists in private practice. The SWG emphasizes the need for psychometric testing when 
evaluating an individual for the FAS diagnosis, and use of clinical judgment alone could veer away 
from the goal of implementing standard diagnostic criteria for FAS. In addition, such testing will 
facilitate the development of individualized and appropriate treatment plans for diagnosed individ­
uals. These guidelines are intended to provide information concerning the types of CNS abnormali­
ties that might be observed, as well as the level of deficit that can be expected. In addition, they 
seek to support the need for quality assessments administered by trained professionals when estab­
lishing CNS abnormalities associated with the FAS diagnosis. 
These guidelines for assessment of CNS abnormalities for making the FAS diagnosis is in harmony 
with, although not duplicative of, other diagnostic guidelines and systems. The 1999 version of the 
University of Washington 4-digit code and the guidelines developed by Health Canada requires 
performance below the 3rd percentile (2 standard deviations below the mean on standardized test­
ing) in three separate domains in which global deficits count as one domain. Some health systems 
might find this approach useful in situations in which resources for standardized testing are readily 
available. 
Mental health problems and lifelong consequence. Difficulty in any of the functional CNS areas 
described above can lead to maladaptive behavior and mental health problems with lifelong conse­
quences. Commonly co-occurring mental health issues (excluding attention problems) reported by 
clinicians and cited in the scientific literature to date, include conduct disorders, oppositional defi-
ant disorders, anxiety disorders, adjustment disorders, sleep disorders, and depression (81,95,131-
134). Although attention problems can be classified as a mental health issue or psychiatric condi­
tion, in these guidelines they are treated as a primary deficit resulting from alcohol-related CNS 
damage, rather than a secondary mental health issue. There are considerable animal, human, and 
clinical studies that document attention deficits for many individuals with prenatal exposure to 
alcohol (117). In addition, decreased adaptive skills and increased problems with daily living abili­
ties have been consistently documented, although further research is needed . Such problems 
include dependent living conditions, disrupted school experiences, poor employment records and 
encounters with law enforcement (including incarceration; 95). Although these mental health and 
very debilitating lifelong consequences should not be used for the purpose of diagnosis, it should be 
noted that they are very prevalent among individuals with FAS and are very likely to be the present­
ing conditions that should trigger a referral and comprehensive diagnostic evaluation. 
Differential diagnosis of CNS abnormalities. Differential diagnosis of CNS abnormities involves not 
only ruling out other disorders but also specifying co-occurring disorders. The CNS deficits associ­
ated with FAS, in particular functional deficits, can be produced by many different factors in addi­
tion to prenatal alcohol exposure. It is important to determine that the observed functional deficits 
are not better explained by other causes. In addition to other organic syndromes that produce 
deficits in one or more of the previously cited domains (e.g., Williams syndrome and Down syn­
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drome), significantly disrupted home environments or other external factors can produce functional 
deficits in multiple domains that overlap with the domains that are affected by FAS. In making the 
differential diagnosis of FAS by ruling out other syndromes, CNS abnormalities should be evaluat­
ed in conjunction with dysmorphia and laboratory findings. The more difficult differentiation is for 
CNS abnormalities resulting from environmental influences (e.g., abuse or neglect, disruptive 
homes, and lack of opportunities). To assist with differential diagnosis between FAS and environ-
mental causes for CNS abnormalities it is important to obtain a complete and detailed history for 
the individual and his or her family. 
In addition to ruling out other causes for CNS abnormalities, a complete diagnosis should identify 
and specify other disorders that can co-exist with FAS (e.g., autism, conduct disorder, and opposi­
tional defiant disorder). It is very important to note that a particular individual might have a con-
duct disorder in addition to FAS, but that not all persons with a conduct disorder have FAS and 
not all individuals with FAS will have a conduct disorder. Thus, organic causes, environmental 
contributions, and comorbidity should all be considered for both inclusive and exclusive purposes 
when evaluating someone for the FAS diagnosis (62,135). Finally, differential diagnosis for the 
CNS abnormalities within the FAS diagnosis is extremely difficult and should be conducted by pro­
fessionals trained not only in the features of FAS, but also in the features of a broad array of birth 
defects and developmental disabilities so as to understand the distinguishing characteristics. 
Maternal alcohol exposure. Documentation and confirmation of prenatal alcohol exposure can be 
extremely challenging. For birth mothers, admission of alcohol use during pregnancy can be very 
stigmatizing. The situation can be further complicated if the woman is still using alcohol, especially 
at high consumption rates. In this situation, information about alcohol use might need to be 
obtained from other reliable informants, such as a relative. However, the overwhelming situation 
encountered in the clinical setting is when a child or adult is being evaluated for FAS and little or 
no information about the index pregnancy is available. This frequently occurs for children in foster 
and adoptive homes. In this situation, every effort should be made to obtain the necessary informa­
tion, but lack of confirmation of alcohol use during pregnancy should not preclude an FAS diagno­
sis if all other criteria are present. This would be considered “unknown prenatal alcohol exposure”. 
In very rare instances, there will be confirmed absence of exposure. Documentation that the birth 
mother did not drink any amount of alcohol from conception through birth would indicate that 
the FAS diagnosis is not appropriate. This typically implies that the birth mother knew the date of 
conception (e.g., a planned pregnancy) and did not consume alcohol from that day forward, or she 
was prevented from drinking for some reason (e.g., incarceration). It must be noted that simple 
denials of alcohol use might or might not be credible and corroborating evidence should be 
obtained whenever possible. However, given the imprecise nature of exposure information, the fol­
lowing two qualifiers for prenatal alcohol exposure were suggested by the SWG: 
I. Confirmed prenatal alcohol exposure requires documentation of the alcohol consumption 
patterns of the birth mother during the index pregnancy based on clinical observation; self-
report; reports of heavy alcohol use during pregnancy by a reliable informant; medical records 
documenting positive blood alcohol levels, or alcohol treatment; or other social, legal, or 
medical problems related to drinking during the index pregnancy. 
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II. Unknown prenatal alcohol exposure indicates that there is neither a confirmed presence nor 
a confirmed absence of exposure. Examples include: the child is adopted and prenatal expo-
sure(s) is unknown; the birth mother is an alcoholic, but confirmed evidence of exposure 
during pregnancy does not exist; and conflicting reports about exposure exist that cannot be 
reliably resolved. 
CRITERIA FOR FAS DIAGNOSIS 
A diagnosis of FAS requires the presence of all three of the following findings: 
1. Documentation of all three facial abnormalities (smooth philtrum, thin vermillion border, 
and small palpebral fissures); 
2. Documentation of growth deficits; and 
3. Documentation of CNS abnormalities (structural, neurological or functional, or combination 
thereof ). 
It should be noted that confirmed prenatal alcohol use can strengthen the evidence for diagnosis, 
but is not necessary in the presence of all the previous findings. Confirmed absence of alcohol 
exposure would rule out the FAS diagnosis. The FAS diagnosis should be made only after ruling 
out other possible diagnoses associated with each criterion. A brief outline of the diagnostic criteria 
for FAS is presented in Table 3. 
Changes in presentation of criteria across development. As would be expected for any congenital syn­
drome, presentation of the diagnostic features can change over development. With regards to facial 
features (small palpebral fissures, smooth philtrum, and thin vermillion border), it has generally 
been accepted that these features are most evident during infancy and the early preschool years. 
However, longitudinal data that specifically address this issue are not available currently. One also 
might expect growth parameters to change (and generally normalize) with development. This might 
especially be the case for children who receive nutritional or other interventions. Perhaps the criteri­
on for which the most change over development is observed is CNS abnormalities. While structural 
abnormalities would remain consistent, neurological and functional deficits could resolve or change 
presentation at various stages of development. During the newborn and infancy periods, difficulty 
with arousal or behavior regulation might be observed. Slightly older infants could display delayed 
or abnormal motor skills. During late infancy approaching the preschool period, general cognitive 
developmental delay is generally reflected through delayed milestones, especially early language 
acquisition (note, however, that basic language skills of vocabulary and syntax generally are not 
areas of deficit for children with FAS). During the preschool period, attention problems and hyper­
activity can emerge. In typically developing children, the late preschool through early school age 
(e.g., 4 through 7 years of age ) is when many executive functioning and social perception skills are 
acquired. For example, simple planning or organization skills are learned, as well as understanding 
the physical and mental perspective of others. Preschoolers and school-aged children often do not 
fully acquire these skills. Throughout the school-age period, children with FAS can exhibit deficits 
or difficulty with any of the CNS domains listed in the diagnostic criteria. However, each child’s 
pattern of strengths and weaknesses is likely to be very individualized. During adolescence and 
through adulthood, the pattern of deficits continues to be present and in addition, lifelong conse­
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Table 3: Brief Outline of Diagnostic criteria for Fetal Alcohol Syndrome 
Facial dysmorphia 
Based on racial norms, individual exhibits all three characteristic facial features: 
• Smooth philtrum (University of Washington Lip-Philtrum Guide rank 4 or 5) 
• Thin vermillion border (University of Washington Lip-Philtrum Guide rank 4 or 5) 
• Small palpebral fissures (at or below 10th percentile ) 
Growth problems 
Confirmed prenatal or postnatal height or weight, or both, at or below the 10th percentile, 
documented at any one point in time (adjusted for age, sex, gestational age, and race or ethnici­
ty). 
Central Nervous System Abnormalities 
I. Structural 
1) Head circumference (OFC) at or below the 10th percentile adjusted for age and sex. 
2) Clinically significant brain abnormalities observable through imaging. 
II. Neurological 
Neurological problems not due to a postnatal insult or fever, or other soft neurological 
signs outside normal limits. 
III. Functional 
Performance substantially below that expected for an individual's age, schooling, or cir­
cumstances, as evidenced by: 
1. Global cognitive or intellectual deficits representing multiple domains of deficit (or significant 
developmental delay in younger children) with performance below the 3rd percentile (2 stan­
dard deviations below the mean for standardized testing) 
or 
2. Functional deficits below the 16th percentile (1 standard deviation below the mean for stan­
dardized testing) in at least three of the following domains: 
a) cognitive or developmental deficits or discrepancies 
b) executive functioning deficits 
c) motor functioning delays 
d) problems with attention or hyperactivity 
e) social skills 
f ) other, such as sensory problems, pragmatic language problems, memory deficits, etc. 
Maternal Alcohol Exposure 
I. Confirmed prenatal alcohol exposure 
II. Unknown prenatal alcohol exposure 
Criteria for FAS Diagnosis 
Requires all three of the following findings: 
1 Documentation of all three facial abnormalities (smooth philtrum, thin vermillion bor­
der, and small palpebral fissures); 
2. Documentation of growth deficits 
3. Documentation of CNS abnormality 
20 
Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis 
quences of those deficits emerge, including mental health problems, inability to achieve independ­
ent living, and criminal activity (62,95,126-137). 
Individuals who do not meet the full diagnostic criteria for FAS. The 1996 IOM report noted that 
most individuals with deficits resulting from prenatal exposure to alcohol do not express all of the 
features necessary to meet the criteria for an FAS diagnosis. This was confirmed in the comments of 
researchers, clinicians, and members of the NTFFAS/FAE during the deliberations of the SWG. 
Consensus has not been reached by either of these groups, or the scientific and clinical community 
at large regarding evidenced-based diagnostic criteria for any prenatal alcohol-related condition 
other than FAS. However, there is grave concern that individuals who present with the same neu­
rodevelopmental deficits as individuals diagnosed with FAS, but who do not present with the full 
facial features or growth deficits, are not being afforded services because they are not given a diag­
nosis of FAS. Ongoing funding has been provided by the National Institute on Alcohol Abuse and 
Alcoholism (NIAAA) to conduct research that might result in evidence-based diagnostic criteria for 
individuals with other conditions caused by prenatal alcohol use. Currently, CDC is using a collab­
orative database of neurodevelopmental data from five intervention studies to explore the nature of 
individuals who could be considered in the diagnostic category of ARND, as well as data from a 
prospective cohort study of 5-year-olds in Denmark. However, at this time, the only diagnostic cat­
egory with scientific evidence to support clinical criteria is FAS. As future data and science are avail­
able, these guidelines can be refined and expanded to delineate other conditions resulting from pre­
natal alcohol exposure. 
CONSIDERATIONS FOR A REFERRAL FOR AN FAS DIAGNOSTIC EVALUATION 
Very often the front-line providers of services (medical, educational, or social) are faced with mak­
ing the decision of whether or not to refer a child, individual, or family for a full FAS diagnostic 
evaluation. The SWG recognizes that this may be a difficult decision. For biological families, there 
may be social stigma associated with any evaluation concerning prenatal alcohol exposure. In other 
families, direct information about alcohol use during pregnancy may not be available or only sus­
pected. Thus, the following guidelines were developed to provide assistance in making the referral 
decision, although, it is recognized that each case must be evaluated individually. Further, these 
guidelines were developed with the idea that when in doubt, it was preferable to refer for full evalu­
ation by a multidisciplinary team with experience in evaluating prenatal alcohol exposure. 
• For situations with known prenatal alcohol exposure: A child or individual should be referred for 
full FAS evaluation when there is confirmed significant prenatal alcohol use (i.e., 7 or more 
drinks per week or 3 or more drinks on multiple occasions, or both). If prenatal alcohol exposure 
in the high risk range is known in the absence of any other positive screening criteria, the primary 
healthcare provider should document this exposure and closely monitor the childs ongoing 
growth and development. 
• For situations with unknown prenatal alcohol exposure: A child or individual should be referred 
for full FAS evaluation when: 
– there is any report of concern by a parent or caregiver (foster or adoptive parent) that his or 
her child has or might possibly have FAS. 
– all three facial features are present (smooth philtrum, thin vermillion border, and small palpe­
bral fissures). 
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– one or more facial features are present in addition to growth deficits in height or weight, or 
both.

– one or more facial features are present, along with one or more CNS abnormalities. 

– one or more facial features are present, along with growth deficits and one or more CNS

abnormalities. 
SERVICES APPROPRIATE FOR AFFECTED INDIVIDUALS AND THEIR FAMILIES 
Diagnosis is never an endpoint for any individual with a developmental disability and his or her 
family. This is particularly true for individuals with FAS, their families, and their community. As 
described in the framework section, the FAS diagnosis and the diagnostic process (especially the 
neuropsychological assessment) are part of a continuum of care that identifies and facilitates appro­
priate health care, education, and community services. The learning and life skills affected by pre­
natal exposure vary greatly among individuals, depending on the amount of alcohol exposure and 
the timing and pattern of exposure, as well as each individual’s current and past environment (138­
139). As a result, the services needed for individuals with FAS and their families vary according to 
what parts of the brain have been affected, the age or level of maturation of the person, the health 
or functioning of the family, and the overall environment in which the person is living. Thus, serv­
ice needs for any particular individual and his or her family can be quite individualistic (140). 
Despite the required individualization in service needs, some general areas of service and specific 
services have been identified as helpful to people with FAS and their families (62). While the ideal 
circumstance are services and interventions that have been specifically developed for individuals 
with FAS and their effectiveness has been established through rigorous scientific evaluation, such 
programs are only now being researched and developed. Thus, most evidence for the benefit of 
services has been gleaned from research with other populations, clinical wisdom, and family experi­
ences. These three sources have drawn heavily from information obtained concerning risk and pro­
tective factors that have been found through systematic research, using natural history methodolo­
gy, to promote positive development or reduce the incidence of negative long-term consequences of 
FAS (i.e., reduce secondary conditions; 141). First, these factors will be reviewed. Then, services 
that are applicable to all individuals with FAS, regardless of life stage will be presented. Finally, 
essential services appropriate for individual life stages will be presented. 
Risk and Protective factors. In a landmark study of secondary conditions for individuals with FAS, 
Dr. Ann Streissguth and her colleagues delineated not only the lifelong consequences of FAS, but 
also several basic factors that are protective or increase the risk of negative outcomes (95). This 
study identified many lifelong negative consequences of FAS, including disrupted school experi­
ences, legal problems, incarceration, mental health problems, substance abuse problems, inappropri­
ate sexual behavior, dependent living, and poor employment history. Importantly, these risks are 
not mutually exclusive. Any individual can (and most likely will) experience multiple risk factors 
that can have a cumulative effect (141). Moreover, these risks can be exacerbated by family and 
community expectations. Research has shown a relation between the number of risk factors 
encountered by an individual and poor outcomes. Reducing the number and severity of risk factors 
is an important step in providing services to individuals with FAS and their families. The disorder 
of FAS has often been described as a “hidden” disability because of the subtlety of the dysmorphia 
and good basic language skills (e.g., vocabulary and syntax) of many affected individuals. These fac­
tors lead to individuals with FAS being treated inappropriately because of caregivers’ unrealistic 
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developmental expectations. FAS might be either not recognized or mislabeled as stubbornness or 
“bad” behavior by a caregiver, or others who encounter the affected individual (e.g., teachers, 
extended family, and friends). Families raising children with developmental disabilities typically 
report considerable parental stress related to this aspect, particularly for parents of children with 
FAS (62). 
Several factors have been identified that can potentially reduce the odds of long-term negative out­
comes in children with FAS (protective factors), including a stable and nurturing home environ­
ment during the school years, early diagnosis (before 6 years of age), absence of exposure to vio­
lence, few changes in caretaking placements, and eligibility for social and educational services. 
Interventions and services that maximize these protective factors while reducing risk factors will 
provide the best benefit to anyone with FAS and improve their chances for achieving their develop­
mental potential (95,138). 
General Needs. Helpful interventions should include those that stabilize home placement and 
improve parent-child interaction (138). One method for accomplishing this goal is to increase the 
understanding of the disorder by parents, teachers, law enforcement personnel, and other profes­
sionals who might become involved with the affected individual. Children with FAS often need 
unique parenting because of their difficulty with cause and effect reasoning and other executive 
functioning skills. Caregiver education should highlight and explain differences in the thought 
processes of children with FAS from typically developing children and children with other develop­
mental disabilities. This would enable parent s to avoid potentially difficult situations (e.g., avoid­
ing overly stimulating environments) and better manage problems when they do arise. Overall, a 
better functioning family that results from caregiver education promotes the stable, nurturing home 
that has been shown to be a positive protective factor for children with FAS (142). 
Beyond the home environment, other professionals also need increased education and information 
concerning FAS (135). Parents can facilitate this understanding by learning to become advocates for 
their child. Such advocacy includes both linking families with needed community resources and 
making sure that the child receives maximum benefit from that service. Because the myriad of serv­
ice systems is confusing and inconsistent across states, families must be educated about them at the 
local level. The world of social and educational services can be overwhelming, confusing, and 
inconsistent, and usually has a unique vocabulary that must be learned. Thus, it is important that 
along with a diagnosis, clinicians need to help caregivers in learning about available services, how to 
determine which services are appropriate for their child, and how to work productively with service 
providers (62). 
Many prenatally exposed infants and children enter the foster or adoptive care system at an early 
age. A recent study estimated that the prevalence of children with FAS (or a related disorder) in the 
foster care system is 10 times that of the general population (143). However, while protective serv­
ice agencies (PSAs) might have information about a child’s prenatal history, staff members are gen­
erally not knowledgeable about FAS, do not understand the impact of the child’s having FAS, or do 
not communicate the child’s FAS status to other service systems. As a result, foster and adoptive 
families are most often not educated about the long-term effects and are unprepared to meet their 
child’s needs. However, most PSAs require foster parents to take a specified number of educational 
courses annually. These courses should include education about the effects and developmental needs 
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of the child with FAS since the majority of foster parents will encounter at least one child with FAS 
or a related disorder during their time as a foster parent. 
The assessment process is integral to a well-developed treatment plan. As has been emphasized in 
these guidelines, part of the diagnostic process is a comprehensive neuropsychological assessment, 
not only to establish CNS abnormities for the diagnosis, but also to develop the best treatment 
plan possible. Such a treatment plan minimizes risk factors for lifelong negative consequences and 
promotes protective factors that maximize developmental potential. Clinicians and s ervice 
providers must ensure that assessments include communication and social skills; emotional maturi­
ty; verbal and comprehension abilities; language usage; and, if appropriate, referral for medication 
assessments. Finally, it is the responsibility of the community at large to ensure that children with 
disabilities, including children with FAS, have access to and are assimilated into school, recreation­
al, and social activities. 
Age-specific services. Basic child development informs clinicians and service providers that the abili­
ties of any one individual change dramatically at different stages of development. Intervention 
research informs providers that the most effective programs are those that are geared towards an 
individual’s developmental level. There are specific “turning points” during which children demon­
strate rapid and fundamental changes in their understanding of the world and in their problem-
solving skills (e.g., development of object permanence or acquisition of formal operational 
thought). The services identified in the following sections include those for both the child and the 
family, grouped broadly by developmental stage. It is recognized that many of these services span 
beyond a single age category with considerable overlap, especially for the family. 
Prenatal services. Significant development of all major organ systems occurs throughout gestation; 
thereby, making it imperative that women who drink during pregnancy be identified by the med­
ical community as early as possible and be provided intervention services. Findings have indicated 
that children born to women who stop drinking at any point during their pregnancy have better 
outcomes than those who continue to drink throughout pregnancy (73). To ensure this happens, 
physicians, nurses, and other allied health professionals need to be trained to screen patients for 
possible alcohol use, to understand the detrimental effects of prenatal exposure to alcohol, to 
understand alcoholism as a treatable disorder, and to be familiar with treatment services. Many 
women who drink during pregnancy and their partners are not educated about FAS or the harmful 
effects of drinking during pregnancy. These prospective parents might not be prepared to address 
their shame or the needs of their children. Some women who experience an alcohol-exposed preg­
nancy might have been exposed themselves prenatally to alcohol. Therefore, treatment personnel 
need to be educated about both FAS and needed services to provide more appropriate treatment, as 
well as provide ongoing support and monitor these families closely. 
Services for birth to 3 years of age. The first years of life are an important time for physical, cognitive, 
and emotional development. Decades of research have consistently shown the benefits of early 
intervention for children with developmental disabilities. Clinicians working with this age group 
need to familiarize themselves with the state systems that service this population. In particular, Part 
C of the Individuals with Disabilities Education Act (IDEA) provides early intervention for chil­
dren 0 to 3 years of age . In many states, this program is administered through local health depart­
ments. A particularly appealing aspect of the Part C portion of IDEA is that FAS is considered a 
“presumptive eligibility” diagnosis. Presumptive diagnoses allow children “at risk” of later develop­
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mental delay to be served without meeting particular eligibility criteria. That is, children who are at 
risk for later developmental problems can receive services, even if they test in the normal range or 
do not meet other eligibility criteria. This is very important for children with FAS because only 
about 25% score in the significantly developmentally delayed range (or the range of mental retarda­
tion for older children; 95). Referring children who have the FAS diagnosis as well as children who 
are exposed but do not meet the full diagnostic criteria for FAS, ensures that these children are 
monitored and, at appropriate ages, referred to appropriate ancillary services as needed. Many states 
maintain birth defects registries that track the ICD-9 code encompassing FAS (i.e., 760.71 Fetal 
Alcohol Syndrome) which also can facilitate such monitoring. All infants who are known to have 
been exposed prenatally included in these registries can be referred to the state’s special child health 
services (note: each state will have its own name for this service) that are part of all states’ maternal 
and child health systems. Special child health services programs provide case management and refer­
ral services for children with birth defects or developmental disabilities as well as facilitate evalua­
tion for early intervention programs. 
As noted previously, a stable and nurturing caregiving environment is a protective factor for chil­
dren with FAS. Child development literature states that stable and nurturing environments pro­
mote secure attachments between infants and caregivers (144). Secure attachment facilitates emo­
tional, social, and personality development in positive ways. Insecure or negative attachment can 
lead to inappropriate development in these areas, and at the most severe end of the continuum, the 
psychopathology of reactive attachment disorder (RAD). The time between birth and 3 years of age 
has been shown to be a particularly salient time for development of child and caregiver attachment. 
Disruption in the caregiving environment can lead to poor or negative attachment between infant 
and caregiver (145). Because many children with FAS are in the foster care system and experience 
multiple placements (due both to the nature of the system and the difficulty in parenting a child 
with FAS), they are at tremendous risk for negative attachment including RAD. 
Services for children 3 to 6 years of age and school age. It is often during the toddler period that chil­
dren with FAS will be identified and can be diagnosed. It is essential that states establish FAS diag­
nostic centers or ensure that their child evaluation centers have clinicians who are trained in the 
dysmorphic and other diagnostic criteria associated with prenatal exposure. 
Following the families themselves, the educational system serves as the most constant service 
provider for individuals with FAS from early childhood through adolescence. Therefore, beginning 
with preschool programs and through secondary education, generalized essential services can be 
delineated. When a child reaches three years of age, early intervention services (IDEA Part C) end 
and families are referred to preschool handicapped programs (sometimes called special needs pre­
school) that are administered through IDEA Part B. Part B of IDEA differs from Part C in that 
there are no presumptive eligibility diagnoses. Eligibility for educational services under this program 
is related entirely to functional criteria and their relation to educability. As noted previously, this 
can make it difficult for children with FAS to qualify for these special education services because 
only a quarter of the children with FAS achieve standardized test scores in the range of significant 
developmental delay (or mental retardation), the usual eligibility threshold. However, within the 
IDEA framework, there are a few categories that allow children with FAS who score above the eligi­
bility threshold to still qualify. A few children with FAS will qualify in the category of learning dis­
abled (LD). This category is for children who demonstrate a statistically significant discrepancy (2 
standard deviations or more) between overall IQ and one or more academic skills (e.g., math). 
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Another eligibility category that has been helpful in qualifying children with FAS is behavior disor­
der. However, this category should be used with care because children with FAS can learn negative 
behaviors from other children without receiving the benefits of a structured environment. Finally, 
the category of other health impaired (OHI) can be used at the discretion of the individual educa­
tion plan (IEP) committee, which includes parents as well as school personnel. Services available 
through the school system go beyond classroom settings. Children can receive various therapies, 
including physical therapy (usually most appropriate for very young children), speech and language 
therapy, occupational therapy, or social skills training. These last two areas are particularly helpful 
to children with FAS because of the visual-motor deficits and problems in social interactions they 
encounter. 
Training parents to be effective educational advocates is essential to maximize the benefits of their 
child’s special education and to understand their child’s rights. The purposes of the IEP are to 
insure access to appropriate habilitation and rehabilitation services (physical, occupational, speech, 
behavioral, mental health, and other related services) and to ensure that academic curricula are bal­
anced with vocational training and skills of daily living (e.g., personal hygiene, money manage­
ment, and family life education), when appropriate. In addition to training parents about the edu­
cational system, the preschool period, as well as elementary school years, are times when parents 
become more acutely aware of their child’s imitations. Reinforcement and updating of information 
learned in early parent education settings will benefit both the child and the parents. Reviewing les­
sons learned will help parents adjust their expectations for the child’s current functioning, as well as 
his or her future possibilities. 
As noted previously, it is important that school staff be trained to recognize possible characteristics 
associated with FAS, as well as appropriate techniques for instructing students with FAS. 
Irrespective of whether alcohol-exposed children are in regular or handicapped preschool programs, 
educational methodologies need to be developed that best address their learning styles and that 
appropriate behavioral or mental health services are available and initiated. 
Beyond services available through the educational system, families raising preschool and school-
aged children continue to need services to promote positive family functioning. Such services might 
include behavior management training, family (or child) counseling, parenting workshops that 
focus on the unique aspects of parenting a child with FAS, or other types of continuing education. 
One service that becomes very important during these years is respite care. Such care allows a 
trained individual to stay with the affected child while caregivers or other family members take 
advantage of some time away from the child with FAS. Respite care has been shown to significantly 
reduce family stress and improve family functioning (146-147). Unfortunately, respite care, espe­
cially formalized and high-quality respite care, is not readily available in most communities. A clini­
cian can help in this situation by working with the family to develop informal respite care situa­
tions, such as help from an extended family member working with the family and to provide the 
necessary education about FAS to such a respite care provider. 
Services for adolescents. Adolescence, and even preadolescence, is one of the major turning points in 
the life of an individual with FAS. His or her body is changing, cognitive abilities are changing, 
peer groups are changing, and community expectations are changing. Because of the confusing 
nature of all these changes, adolescence often is the period when behavioral and mental health 
problems become more pronounced. Depression or anxiety, or both, can set in as the individual 
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struggles to cope with these changes. Increased opportunities to experience alcohol and/or drugs 
can lead to substance abuse problems. Families could become involved with juvenile or criminal 
justice systems. These are some of the most serious secondary conditions that research has identified 
for individuals with conditions associated with prenatal alcohol exposure (95). 
It is often during adolescence that families experience high levels of stress and tension. As such, the 
need for individual counseling (for both child and parent), family counseling, and a strong support 
network becomes more crucial. However, this can be the exact stage at which agencies are reluctant 
to provide such services, especially if the FAS-related disability factor is not recognized. Because 
some amount of rebellion is expected during adolescence, the challenging behaviors of the teenager 
with FAS might be dismissed as transient. At the other end of the spectrum, the challenging behav­
iors of the adolescent with FAS can be so severe as to involve the criminal justice system. 
Because adolescents will soon be leaving the safety and structure of the educational system, voca­
tional and transitional services become essential during this stage. These services often represent a 
shift from academic skills and achievements to daily living skills, including employment skills. It is 
very important that these services be started in early adolescen ce, and not left until the individual 
is about to age-out of the educational system. In addition, beyond teaching the specific skills that 
go with a particular job, it might be necessary to explicitly teach those skills related to being a good 
employee (e.g., punctuality and minimized socializing). Most individuals will learn these skills 
through basic maturity and observational learning. Individuals with FAS often need explicit instruc­
tion as well as lifestyle supports (e.g., a job coach). 
As for all adolescents, sexual behavior often becomes a critical issue during this stage. The bound­
aries for appropriate interaction with the opposite sex, the subtle nature of social cues, and impulse 
issues are difficult for any adolescent, but more so for the adolescent with FAS. Close supervision is 
the first line of defense during the adolescent years. However, such supervision often conflicts with 
the adolescent’s growing desire for independence. This must be navigated with care to avoid alienat­
ing the adolescent. Also, it is probably best to be open and explicit with the teenager with FAS con­
cerning the issues of contraception, sexually transmitted diseases, and sexual harassment. Failure to 
address these issues can have serious, and possibly life-threatening consequences for the affected 
individual, his or her family, and any children resulting from unintended pregnancies. 
As mentioned previously, individuals with FAS are at high risk for involvement with the juvenile 
and criminal justice systems. Their lack of executive functioning skills (i.e., poor judgment), fluid 
language skills, and naïve social skills make them particularly vulnerable to participating in criminal 
activity. However, these same deficits demand that when they do encounter the justice system, their 
deficits should be taken into account during all aspects of justice proceedings (i.e., charges, process, 
punishment, and rehabilitation). As such the juvenile and criminal justice systems are major social 
systems in need of education regarding FAS. Special rehabilitation programs with staff that are 
trained to work with adolescents and young adults with FAS should be established. Such programs 
should be based on scientifically-based research findings that evaluate practicality as well as effec­
tiveness. 
Services for adults. In addition to all the services mentioned for the preceding age groups, adults 
with FAS often need support in every area of their lives. Everyday needs such as transportation 
issues, job assistance, housing assistance, medication reminders, money assistance, and support and 
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assistance when unpredicted issues arise should continue to be monitored and supported. Although 
not consistently available, clearly a system needs to be established that assists people with FAS in 
living as independently in the community as possible and includes support for housing, healthcare, 
and employment. 
Because of federal, and often state legislation, it is very difficult for people with FAS to receive serv­
ices from state developmental disability agencies, unless exposed individuals have met the eligibility 
criteria for services before 22 years of age. Eligibility criteria are generally based on levels of intelli­
gence, as well as functional limitations in at least three areas associated with skills of daily living. As 
a result, many exposed individuals will not be eligible for services that often include an individual 
service plan (ISP), case management, residential and employment assistance, and possibly social 
security disability payments. 
People with FAS might be eligible for federal assistance, such as, Medicaid, Supplemental Security 
Income (SSI), and Section 8 Housing subsidies, not because of their disabilities but because of their 
low income status. However, obtaining these services can be difficult. For example, most states have 
long waiting lists for Section 8 housing because of both the high demand and great need often lead­
ing to a shortage of rental units. Eligibility criteria for these services, even when based on income, 
should include a priority category for persons with FAS. Unfortunately, many of these housing 
options do not offer the support and structure that adults with FAS often need. Housing remains 
one of the main issues in supporting individuals with FAS for which there are no appropriate serv­
ices developed or identified. 
IDENTIFYING AND INTERVENING WITH WOMEN AT RISK FOR AN ALCOHOL­
EXPOSED PREGNANCY 
Despite ongoing efforts to inform childbearing-aged women of the risk associated with alcohol use 
during pregnancy, surveys conducted by the CDC and SAMHSA indicate that 9% to 12% of preg­
nant women in the United States report consuming alcohol and that approximately 3% report 
drinking at levels than have been consistently associated with adverse effects on the fetus (148-149). 
Also of concern are the high proportions of non pregnant childbearing-aged women whose drink­
ing patterns exceed safe levels as defined by public health agencies (150-151). Currently more that 
half of all women of childbearing age (18 through 44 years of age) report alcohol use, and one in 
eight report binge drinking in the past month. Many of these women are sexually active and are 
not taking effective measures to prevent pregnancy. These women are at risk for an alcohol-exposed 
pregnancy in that they could have an unrecognized pregnancy and continue drinking early in preg­
nancy at levels that are harmful to the fetus. 
One public health strategy for preventing alcohol-exposed pregnancies is to identify characteristics 
of women at greatest risk of having a child affected by prenatal alcohol exposure and implement 
prevention programs in subpopulations with higher proportions of these identified risk factors. 
Over the past 20 years, concerted efforts have been made to identify factors among childbearing-
aged women associated with harmful patterns of alcohol consumption. One extensive review of 
studies reporting characteristics of women giving birth to a child with FAS found that low socioe­
conomic status (SES), African-American and American-Indian/Alaska-Native ethnicity, and being a 
smoker were characteristics commonly found among women in this group (152). Additional studies 
using cross-sectional survey data and special populations have extended our understanding of char­
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acteristics associated with childbearing-aged women at high risk for having an alcohol-exposed 
pregnancy based on current drinking patterns. Factors associated with risk include being a smoker, 
having a low SES, being unmarried, having a history of previous or current illicit drug use, having a 
history of physical or sexual abuse, having psychological stress, and having mental health disorders 
(153-156). In an attempt to identify community-based settings that have higher proportions of pre-
conceptional women at increased risk for an alcohol-exposed pregnancy, CDC sponsored an epi­
demiological study of special populations that included: women in alcohol and drug treatment cen­
ters, a large urban jail, publicly funded primary care clinics, a university-based gynecology clinic in 
a large urban hospital, and a cohort of women responding to a newspaper solicitation (27). Being at 
risk for an alcohol-exposed pregnancy correlated significantly with being (or having ever been) a 
smoker, having a history of inpatient treatment for drugs or alcohol, having a history of inpatient 
mental health treatment, having multiple sex partners, and having experienced recent physical 
abuse. 
Primary prevention of alcohol-exposed pregnancies requires the accurate identification of women 
who are drinking at thresholds that have been associated with adverse pregnancy and infant out­
comes before pregnancy occurs. Dietary guidelines from the U.S. Department of Health and 
Human Services recommend that women drink no more than one drink per day to avoid increased 
risk for adverse health conditions and that women who are pregnant, planning a pregnancy, or at 
risk of pregnancy abstain from alcohol use altogether. Research findings support these recommen­
dations with evidence of increased risk for birth defects, spontaneous abortions, and deficits in neu­
rocognitive development and growth at levels of seven or fewer drinks per week in some studies 
(157-162). 
Of further concern is the pattern in which alcohol is consumed. Heavy episodic drinking, as in 
binge drinking, can result in increased severity of the teratogenic exposure effects because of the 
higher peak blood alcohol levels achieved in this pattern of consumption as opposed to lower level 
daily consumption (40,163). Historically, a binge episode has been considered to be five or more 
drinks on any one occasion, but evidence of the presence of gender effects in alcohol metabolism 
and higher morbidity and mortality among women than men with similar consumption patterns 
has prompted recommendations for defining a binge episode for women as four or more drinks on 
any one occasion or on any one day. Current recommendations on clinical thresholds published by 
the NIAAA are that women drinking more than seven drinks per week or more than three drinks 
on any given day in the past month be further assessed for risk of developing alcohol-related prob­
lems. As stated earlier, pregnant women are advised to abstain from alcohol use. This is a long-
standing federal advisory and one supported by major professional societies as well (9,164). 
Measurement of current alcohol consumption can be enhanced through the use of reliable screen­
ing and assessment methods. A number of screening instruments have been developed that offer the 
practitioner options for clinical assessment of childbearing-aged women. When selecting a screening 
tool for routine implementation, healthcare professionals should consider factors such as the goals 
of the screening process, the target population, and the ease of administration. All women of child­
bearing age should be screened for alcohol use, including women who are pregnant or nursing, 
women who are planning a pregnancy, and women who are sexually active and not using contra­
ception (such as teens and college-aged women). 
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Methods and Considerations for Establishing Reliable Estimates of Alcohol Use. Measures most com­
monly used in alcohol assessment include items that address quantity, frequency, and pattern (vari­
ability) of drinking. Quantity-frequency measures (QF) inquire about average or typical consump­
tion patterns. The simplest measures assess the amount of drinking on average drinking days (Q), 
and the average number of days on which alcohol is consumed (F). QF measures can be used to 
estimate a woman’s average number of drinks per day or the amount of absolute alcohol consumed 
per day (AA score). To assess for binge drinking, some investigators have recommended that screen­
ing questions should include measures of maximum quantity consumption and frequency of maxi­
mum quantity consumption (165). Helping Patients with Alcohol Problems: A Practioner’s Guide, 
developed by the NIAAA, (166) recommends quantity-frequency and maximum quantity questions 
as the primary screening test. These questions have been shown to have relatively high sensitivity 
and specificity, are easy to use, and can be incorporated into a health practice with minimal cost 
and effort (167). 
Additional considerations for alcohol screening include measurement of the types of alcoholic bev­
erages the woman consumes. The development of new ways of marketing wine and beer, including 
higher alcohol concentration malt liquors and beer in 20- to 45-ounce containers, has increased the 
need to provide women who drink with more specific standards to estimate their consumption. 
Studies show that reliance on standard drink measurements when assessing drinking practices of 
heavier drinkers or those consuming higher alcohol content beverages can result in considerable 
underestimation of alcohol consumption (168-169). Moreover, beverage-specific questions have 
been shown to be more accurate than grouped beverage questions (170). 
One of the most reliable assessment tools for gathering accurate self-reported alcohol use is the 
timeline follow back (TLFB) measure (171). This method of alcohol use assessment typically asks 
respondents to think back over the past 90 days and report daily drinking amounts during that 
period of time. Respondents are given a calendar and asked to identify special events that occurred 
during that time period, such as parties, birthdays, or holidays that might serve to trigger recall of 
drinking occasions. A major strength of the TLFB measure is its ability to capture both average 
daily drinking and sporadic drinking that might entail drinking at higher levels of consumption. 
Because of the time requirements necessary for gathering information using the TLFB approach, it 
is not easy to use in primary care settings but it has been used in clinical research to establish the 
reliability and validity of other briefer screening and assessment tools (172). 
Screening Tools. Several brief questionnaires have been developed over time to screen for problematic 
alcohol use in adults in diverse populations and settings. Screening tools currently in use include 
the CAGE, AUDIT, T-ACE, TWEAK, MAST, S-MAST, NET, RAPS4, and RAPS4-QF (173). The 
CAGE (174)is a four-item alcohol use measure designed to detect alcoholism and is one of the 
most commonly used screening instruments for men and women. The four questions ask the 
respondent: (C) Have you ever felt you should CUT down on your drinking? (A) Have people ever 
ANNOYED you by criticizing your drinking? (G) Have you ever felt bad or GUILTY about your 
drinking? and (E) Have you ever had a drink first thing in the morning to steady your nerves or to 
get rid of a hangover (EYE OPENER)? Each item is scored as a 0 (no) or 1 (yes) and scores of 2 or 
greater are considered clinically significant. 
The AUDIT is a 10-item self-report questionnaire developed by the world health organization 
(WHO) for identifying individuals whose alcohol consumption has become hazardous or harmful 
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to their health (175). The items on the AUDIT are constructed to measure frequency of alcohol 
consumption, dependence symptoms, and the personal and social consequences of drinking. The 
first three questions of the AUDIT address the quantity, frequency, and maximum amount of alco­
hol consumed. The remainder of the questionnaire has two items from the CAGE, (feelings of guilt 
about drinking and the need for a drink first thing in the morning after a heavy drinking session— 
eye-opener) in addition to questions on the frequency of being unable to stop drinking once drink­
ing starts, frequency of being unable to do what is normally expected because of alcohol use, fre­
quency of memory loss of the previous night due to drinking, frequency of injury to self or others 
as a result of drinking, and frequency of others expressing concern over the individual’s drinking (a 
relative, friend, or doctor). A score of eight or more is considered significant for high-risk consump­
tion. The measure has good psychometric properties and has an advantage over other screening 
tools in that it measures not only experienced consequences of drinking, but also whether an indi­
vidual is currently drinking at levels likely to eventually result in problems (176). The instrument 
has been used and validated in cross-cultural populations (177). One review of 38 studies on 
screening for alcohol problems in women and men in primary care settings found the AUDIT was 
more effective in identifying individuals with at-risk, hazardous, or harmful drinking patterns, 
while the CAGE proved superior in detecting alcohol abuse and dependence (178). Another study 
of women who were receiving outpatient care through the Veterans’ Administration found that the 
AUDIT-C (comprised of the first three items of the AUDIT on quantity, frequency, and maximum 
drinks per drinking occasion) proved to be more sensitive than the full 10-item AUDIT (179). 
Such findings suggest that when time of administration is a consideration, the shorter AUDIT-C 
might be used as the screener of choice. 
Two screening tools that have been specifically developed and used with pregnant women are the T­
ACE and the TWEAK (180-183). The T-ACE has four questions that take less than a minute to 
ask. The questions are: (T) TOLERANCE, how many drinks does it take to make you feel high? 
(A) Have people ANNOYED you by criticizing your drinking? (C) Have you ever felt you ought to 
CUT DOWN on your drinking? (E) EYE OPENER, Have you ever had a drink first thing in the 
morning to steady your nerves or get rid of a hangover? One point is given for each affirmative 
answer to the A, C, E questions, two points when a pregnant woman reports a tolerance of more 
than two drinks to feel high. A positive screen is a score of two or more points. The T-ACE has 
been shown to be an efficient screen for risk drinking in pregnant women and out-performs med­
ical staff assessment alone (184). Its brevity (four-items) is an important asset and increases its utili­
ty for clinical practice. 
Like the T-ACE, the TWEAK attempts to elicit information on the following: (T) TOLERANCE 
for alcohol; (W) WORRY or concern by family or friends about drinking behavior; (E) EYE 
OPENER, the need to have a drink in the morning; (A) “blackouts” or AMNESIA while drinking; 
and (K) the self-perception of the need to CUT DOWN on alcohol use. Scores range from zero to 
seven. The tolerance and worry questions each contribute two points and the other three questions 
contribute one point each. Any endorsement of the worry question is scored a two. On the toler­
ance question, if three or more drinks are needed to feel high, the question is scored as a two. 
Other versions of the tolerance question ask: How many drinks does it take before the alcohol 
makes you fall asleep or pass out? Or, if you never drink till you pass out, what is the largest num­
ber of drinks you have or can hold? These questions are scored as a two if the woman answers five 
or more drinks. Using these questions, however, results in lower sensitivity and specificity. A total 
score of three or more on the TWEAK is suggestive of harmful drinking pat terns (185). 
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Studies assessing the relative effectiveness of various screening tools have yielded different findings 
depending on the populations studied. Bradley et al. (186) summarized data from 13 published, 
peer-reviewed articles that contained information on the performance of alcohol screening ques­
tionnaires with non pregnant women and with obstetric patients during the periconceptional peri­
od. The results revealed that, for non pregnant women, the CAGE had low sensitivity in predomi­
nantly White female populations, but was a reasonable choice for identifying past year or lifetime 
alcohol dependence in predominantly African American female populations. Overall, the five-item 
TWEAK appeared to be the optimal screening questionnaire for identifying heavy drinking or alco­
hol abuse and dependence in racially mixed populations of non pregnant and pregnant women. 
Some clinicians have suggested that the use of screeners best suited for identifying high-risk heavy 
drinkers might not be optimal for identifying pregnant women with irregular or lighter patterns of 
consumption that might still pose a risk for fetal development. Using confidential reporting proce­
dures, one study examined the effectiveness of the TWEAK for assessing any report of drinking fol­
lowing pregnancy recognition in a group of low-income pregnant women participating in WIC 
(187). With a cut point score of two or greater, the specificity of the TWEAK was high for all eth­
nic groups studied; however sensitivity, while high for White non-Hispanic women, was low for 
African-American non-Hispanic and Hispanic women. Because any endorsement of alcohol use was 
sufficient for classification as a drinker in this sample, low sensitivity on the TWEAK might have 
been due to the fact that women were drinking at levels that were too low to result in alcohol-relat-
ed problems but, were still high enough to be detrimental to the developing fetus. From a practical 
standpoint, the high specificity of the TWEAK supports its utility in busy clinic settings. High 
specificity suggests the TWEAK is effective in screening women who are not high risk, and as 
shown in the study cited previously, women who report not drinking at all. Nevertheless, the fact 
that the TWEAK had variable sensitivity for women from different ethnic backgrounds suggests 
that additional methods of screening should be employed in order to increase the detection of 
women who might need intervention. 
Drinking among adolescents and college students has long been recognized as a significant problem 
with far-reaching public health implications (188-189). Although the most problematic drinking in 
adolescence has been documented among males when compared to females, alcohol use in females 
has been associated with decreased use of contraception (increasing the likelihood of an unintended 
pregnancy), increased sexual assault, and more sexually transmitted diseases. Because of these signif­
icant negative health consequences, the American Medical Association Guidelines for Adolescent 
Preventive Services recommend screening of adolescents for alcohol and other drug use as part of 
routine medical care (190). To effectively screen adolescents, the ideal screening tool must be devel­
opmentally appropriate and practical for use in busy medical offices or clinics. Although the CAGE 
and the AUDIT are relatively brief, their developmental appropriateness is questionable. Indeed, 
current research suggests that the CAGE is not appropriate for screening adolescents and that a 
much lower cut point of two (rather than the eight recommended for adults) on the AUDIT is 
optimal for identifying alcohol use problems in this population (191). 
Several measures have been developed specifically for use with adolescents, such as the Rutgers 
Alcohol Problem Index (192) and the College Alcohol Problem Scale (193); however, these tools 
might not be practical for universal screening. One brief screening device, the CRAFFT, developed 
for adolescents, is simple to score, inquires about alcohol and drug use, and was found to have good 
psychometric properties in a sample of predominately female youths 14 through 18 years of age 
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(194). CRAFFT is an acronym for the first letters of key words in the test’s six questions: (C) Have 
you ever ridden in a CAR driven by someone (including yourself ) who was high or had been using 
alcohol or drugs? (R) Do you ever use alcohol or drugs to RELAX, feel better about yourself, or fit 
in? (A) Do you ever use alcohol or drugs while you are by yourself, ALONE? (F) Do you ever 
FORGET things you did while using alcohol or drugs? (F) Does your family or FRIENDS ever tell 
you that you should cut down on your drinking or drug use? (T) Have you ever gotten into 
TROUBLE while you were using alcohol or drugs? Each question on the CRAFFT is given a score 
of one and a cut point of two provides moderate sensitivity (.70) and excellent specificity (.94) for 
identifying alcohol use disorders in adolescents. The authors CRAFFT recommend that any posi­
tive answer on this measure be followed by further assessment of quantity, frequency, and pattern of 
use to increase sensitivity and to guide decisions about the need for intervention. 
A number of studies have shown a strong association between alcohol intoxication and trauma 
(195). The Trauma Questionnaire was developed to screen patients in an unobtrusive way without 
asking them directly about their alcohol use (196). The questionnaire consists of four questions ask­
ing about injuries in the last five years (fractures or dislocations of bones or joints, traffic accidents, 
head injury, or injury during a fight or assault). The questionnaire has been shown to have high 
sensitivity and specificity for identifying high-risk alcohol use and to be acceptable to respondents 
and physicians. 
Computer-Assisted Interviews and Laboratory Screening Measures. The method of delivery of ques­
tions about alcohol use has been shown to influence truthful reporting. Clinical interviews might 
not be as effective in eliciting truthful responses from women because practitioners are not always 
comfortable asking these questions in a face-to-face interview. Moreover, women could underesti­
mate their alcohol use because of reluctance to discuss this potentially sensitive subject. For this rea­
son, self-administered questionnaires might improve the validity of self-report. 
The Audio Computerized Self-Report Interview has been successfully used in prenatal clinics serv­
ing disadvantaged low-literacy minority women (197). Questions asked by a recorded voice through 
earphones are drawn from the TWEAK with quantity and frequency questions pertaining to three 
months before and during pregnancy are included. Acceptability studies have revealed that patients 
liked this method of screening. 
Laboratory screening measures offer promise for obtaining objective evidence of problem drinking 
(198-199). The most common biomarkers are gamma glutamyltransferase (GGT) and carbohy-
drate-deficient transferring (CDT). Fatty acid ethyl esters synthase (FAEE) can be found in the hair 
of alcohol using women. This biomarker could hold promise for screening for alcohol use in preg­
nant women, although the dynamics of enzyme expression appear to be complex and changes occur 
only at high alcohol doses. Low sensitivity in non alcoholic women and the high cost of laboratory 
analysis make these measures less feasible for use in more universal screening. 
Brief Intervention. Brief intervention (BI) has been shown to be a low-cost, effective treatment alter­
native for alcohol problems that uses time-limited, self-help, and preventative strategies to promote 
reductions in alcohol use in nondependent individuals, and in the case of dependent people, to 
facilitate their referral to specialized treatment programs (200-203). Overall, BI for alcohol prob­
lems has been shown to be more effective than no intervention and often as effective as more exten­
sive intervention (204). Effective prevention programs frequently employ a multicomponent 
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approach combining cognitive-behavioral techniques with norms clarification, education, and moti­
vational enhancement interventions. BI is usually restricted to fewer than four sessions and is typi­
cally performed in a treatment setting that is not specific for alcoholism. It is often performed by 
personnel who are not specialists in the treatment of alcohol use and abuse, and is provided to indi­
viduals at varying levels of risk for negative consequences because of drinking, rather than those 
who are considered alcohol dependent (205). 
Six elements characterize the key ingredients of standardized brief intervention summarized by the 
acronym FRAMES (206). These are: Feedback of personal risk, Responsibility for personal control, 
Advice to change, Menu of ways to reduce or stop drinking, Empathetic counseling style, and Self-
efficacy or optimism about cutting down or stopping drinking. The intervention also involves 
establishing a drinking goal in the form of a signed contract and follow up of progress with ongo­
ing support. Studies reveal that supportive, nonjudgmental techniques in which trained personnel 
counsel women can lead to decreased alcohol consumption during pregnancy. The most effective 
intervention approaches avoid the use of moral or volitional injunctions and instead focus on 
reduction of alcohol use without criticism or provocation of guilt (205). Effective interviewers have 
been found to have a thorough knowledge of the intervention technique, an optimistic attitude 
about change, a compassionate style, genuineness and respect for clients, an ability to avoid argu­
ments that evoke patient defensiveness, and comfort discussing alcohol problems (207-208). 
Motivational Interviewing. A technique often used in brief interventions is motivational interview­
ing (MI). MI uses an empathic , client-centered counseling approach to increase readiness for 
change by resolving ambivalence about behavior change (207). The process explores the client’s 
ambivalence in an atmosphere of acceptance, warmth, and positive regard. Although the session is 
structured and to the point, direct persuasion and coercion are avoided. The goal is to enhance the 
discrepancy between the reasons for changing versus staying the same. More than 24 studies of MI 
have found beneficial effects in decreasing problem drinking and other health-related problem 
behaviors (209). 
Manualized Brief Intervention. Although the findings of the previously cited studies provide the 
foundation for intervention and prevention efforts, the usefulness of MI in a busy clinic or medical 
practice might be limited in that it requires additional training and clinical skills development. 
Recently, standardized manualized BI techniques to reduce alcohol consumption have been devel­
oped. One such intervention is Project CHOICES (Changing High-risk alcohol use and Increasing 
Contraception Effectiveness Study), which is funded by CDC. Project CHOICES is an example of 
a brief intervention using motivational interviewing techniques aimed at preventing alcohol-
exposed pregnancies among high-risk women in various community settings (210). This project 
focused on both alcohol risk reduction and pregnancy postponement until alcohol use was 
decreased in a group of non pregnant women who were of childbearing age, fertile, sexually active, 
and using ineffective or no contraception. Phase I results revealed that at six-month follow up, 
68.5% of the women were no longer at risk of having an alcohol-exposed pregnancy, 12.6% had 
reduced their drinking only, 23.1% reported using effective contraception only, and 32.9% report­
ed doing both. A Phase II randomized controlled trial is currently underway testing the efficacy of 
this approach and is slated for completion in fall 2004. Another recent CDC-funded study still 
underway is Project Balance, which uses a briefer adaptation of Project CHOICES and is aimed at 
female college students, encouraging them to abstain from alcohol or to use contraception if they 
drink. 
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Four randomized controlled studies, funded by NIAAA, serve as further examples of the utility and 
effectiveness of this approach. These studies included women of different socioeconomic and cul­
tural backgrounds and were conducted in doctors’ offices and community settings. Two of the stud­
ies found that manualized BI was successful in decreasing alcohol use during subsequent pregnan­
cies in high-risk women, thus preventing possible negative developmental sequelae in their offspring 
(211). The other two studies, one working with high-risk, White, middle class pregnant women in 
physicians’ offices and one working in WIC community clinics with primarily low risk, low-income 
Hispanic clients, also found manualized BI to be a promising approach (212-214). In the WIC 
study, better infant outcomes were reported, including longer birth lengths and a lower infant mor­
tality rate. Significantly, in both studies, the control conditions that included an assessment of alco­
hol consumption and simple advice to stop or cut down on drinking were almost as effective as the 
manualized BI itself. The success of these projects in reducing alcohol consumption in both experi­
mental and control groups was postulated to be due to the desire of pregnant women to have 
healthy pregnancies and to the time and attention that interventionists provided for women in both 
groups. 
Computerized Brief Intervention One recently developed study is investigating the use of a comput­
erized method of a BI that incorporates the use of vessel size and normative education that allows a 
woman to evaluate her own consumption levels (169). Once a woman has been educated about her 
consumption levels, she then participates in a standardized BI. This approach is promising in that it 
incorporates many recommended aspects of screening, educating, and assisting women in recogniz­
ing that they might have a drinking problem, and then providing a brief intervention. The auto­
mated computerized assessment is designed for use in prenatal clinics and is currently being tested 
at a large HMO through an NIAAA grant. Although the effectiveness of this intervention has yet to 
be validated, it offers a potentially useful method that could be expanded nationally. 
Improving Use of Screening and Brief Intervention Technology by Clinicians. Research devoted to find­
ing ways to encourage clinicians to use brief interventions indicates that routine educational 
approaches might not be effective. Effective strategies include (1) conducting educational programs 
at the intervention site; (2) using specific step -by-step, evidence-based clinical protocols; (3) using 
skills-based role playing; (4) holding peer group discussions; and (5) using a credible expert trainer 
or educator. Brevity, repetition, and reinforcement of recommended practices are also key program 
elements (215). In an effort to enhance physician uptake of current screening and intervention 
approaches for preventing alcohol-exposed pregnancies, the NIAAA and the Office of Research on 
Minority Health recently collaborated in the development of a guide for primary care providers for 
screening pregnant and non pregnant women on selected health behaviors, including alcohol use, 
and recommendations for appropriate advice depending on the level of alcohol use and conse­
quences (166). More recently, CDC funded four regional training centers on FAS to provide educa­
tion and training to medical and allied health professionals and students about identification and 
diagnosis of children affected by prenatal alcohol exposure and effective approaches for intervening 
with and preventing these conditions. More information about these and other resources can be 
found by accessing the websites provided at the end of this section. 
Universal screening for alcohol use should be conducted among all women of childbearing age. 
Screening can be done in both physicians’ offices and in community health settings. Simple screen­
ing techniques that include measures of quantity, frequency, and heavy episodic drinking, as well as 
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behavioral manifestations of risk drinking, have proven to be most beneficial. For non pregnant 
women, the AUDIT, TWEAK, and CAGE have been found to be useful screening tools depending 
on the population characteristics of the community as described in the studies reviewed earlier. 
However, studies on gender-specific modifications of these screening tools have been recommended 
because women report increased psychosocial problems at lower levels of consumption than men. 
Based on some empirical evidence, reduced cut points for women have been recommended, includ­
ing a cut point of 4 or more for the AUDIT, 2 or more for the TWEAK, and 1 or more for the 
CAGE (186). For pregnant women, the T-ACE and the TWEAK are the recommended screening 
tools of choice. The CRAFFT shows promise as an alcohol and other drug screener for female ado­
lescents. Findings support better identification when screening instruments are used versus clinical 
assessment alone. Brief interventions administered by physicians and allied health professionals in 
medical and non medical settings are effective in bringing about reductions in drinking. 
Women who are pregnant, planning a pregnancy, or at risk of pregnancy should be advised not 
to drink, as no safe threshold of alcohol use during pregnancy has been established. Non preg­
nant childbearing-aged women should be advised to drink no more than seven drinks per week 
and no more than three drinks on any one occasion. 
Both BI approaches and MI techniques have been found to be efficacious with pregnant and non 
pregnant women in promoting reduction in alcohol consumption. Furthermore, some evidence 
suggests pregnant women are motivated to stop drinking even if the intervention includes only an 
assessment of alcohol use with simple advice to stop or reduce drinking. Research also indicates that 
interventions are effective with pregnant women who are light as well as high-risk drinkers. 
Moreover, preconceptional counseling of women of childbearing age who are at risk for an alcohol-
exposed pregnancy and who are not using effective contraception has been demonstrated as a 
promising method of prevention as well as computerized versions of standardized methods of inter­
vention. This year the U.S. Preventive Services Task Force released recommendations calling for use 
of the screening and behavioral counseling interventions for adults in primary care setting, includ­
ing pregnant women (216-217). These evidence-based recommendations mirror the content of 
these guidelines with respect to the specific types of screening tools recommended and the compo­
nents of effective brief interventions to be used. The recommendations of the U.S. Preventive 
Services Task Force, which is supported by the federal Agency for Healthcare Research and Quality, 
provide further support for the need for widespread public health implementations of these pre­
vention technologies to reduce the harmful consequences of alcohol misuse, including FAS and 
other prenatal alcohol-related conditions. Information about reported and other federally sponsored 
studies in FAS and prenatal alcohol screening and intervention can be obtained at the following 
websites: www.nih.gov; www.cdc.gov; www.samhsa.gov; and www.preventiveservices.ahrq.gov. 
SUMMARY AND FUTURE STEPS 
In 2002, CDC was congressionally mandated to develop diagnostic guidelines for FAS and other 
prenatal alcohol-related disorders and integrate them into medical and allied health education. 
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With input from a SWG composed of clinicians, experts, and families, and from the 
NTFFAS/FAE, scientific and clinical evidence was reviewed to develop guidelines that offer a bal­
ance between conservative and overly inclusive definitions of FAS. Criteria for conditions not meet­
ing the clinical definition of FAS (e.g., ARND) were not established because scientific evidence is 
insufficient at this time. Clinical and scientific research on FAS and those conditions resulting from 
prenatal alcohol exposure that do not meet the criteria for an FAS diagnosis is currently underway. 
These findings and advances will contribute to further refinement of the FAS criteria, and could 
potentially delineate additional diagnostic categories and criteria for conditions other than FAS. 
The development of these FAS guidelines is a continuous process. Efforts to develop and refine 
other diagnostic categories to identify FAS and related conditions need to continue. 
During this guidelines development process, several key issues emerged that deserve mention. 
1. More information on the neurodevelopmental effects of prenatal exposure to alcohol is needed. 
Particular emphasis should be placed on finding the unique aspects of FAS that will help differ­
entiate it from other birth defects or developmental disabilities, or both. 
2. Efforts to improve the clinical assessment tools (e.g., facial and growth measures) used to diag­
nose FAS should continue, particularly in terms of racial and ethnic variations and age. 
3. All children should be screened for the possibility of an FAS diagnosis. As physicians and other 
allied health professionals become educated about this disorder, screening for FAS should become 
routine. 
4. Better communication between obstetricians, gynecologists, and pediatricians is needed to 
improve documentation on prenatal alcohol use. This would help with the diagnosis of prenatal 
alcohol exposure in the child and could help identify women at risk for future alcohol-exposed 
pregnancies. 
5. Service agencies must provide a way to qualify children with FAS and related disorders who do 
not meet their traditional eligibility requirements. 
6. Further research and resources are needed to identify and treat women at risk for an alcohol-
exposed pregnancy. 
7. Awareness, both in the public and professional arenas, about the dangers of drinking alcohol dur­
ing pregnancy and about FAS and how the condition affects children and their families is essen­
tial. A key avenue to avoiding FAS is active promotion of programs to increase awareness of the 
dangers of drinking alcohol during pregnancy and promotion of prevention activities that 
increase understanding of the risks of alcohol as well as the risks for an alcohol-exposed 
pregnancy. 
Over 30 years ago, researchers first described FAS . Much has been learned about the disorder since 
that time, as is reflected in these guidelines. However, there is still much more to learn about the 
entire spectrum of effects from prenatal alcohol exposure. Future work will address these gaps. To 
reduce FAS and other prenatal alcohol-related conditions, the key is prevention. Federal, state, and 
local agencies; clinicians and researchers; educational and social service professionals; and families 
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need to work together to educate women of childbearing age and communities across the country 
about the risks of drinking alcohol during pregnancy. 
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